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1. PUBLIC HEALTH STATEMENT
 
This Statement was prepared to give you information about radium
 
and to emphasize the human health effects that may result from exposure
 
to it. The Environmental Protection Agency (EPA) has identified 1,177
 
sites on its National Priorities List (NPL). Radium has been found
 
above background levels at 18 of these sites. However, we do not know
 
how many of the 1,177 NPL sites have been evaluated for radium. As EPA
 
evaluates more sites, the number of sites at which radium is found above
 
background levels may change. The information is important for you
 
because radium may cause harmful health effects and because these sites
 
are potential or actual sources of human exposure to radium.
 
When a radioactive chemical is released from a large area, such as
 
an industrial plant, or from a container, such as a drum or bottle, it
 
enters the environment as a radioactive chemical emission. This
 
emission, which is also called a release, does not always lead to
 
exposure. You can be exposed to a radioactive chemical when you come
 
into contact with that chemical alone or with a substance that contains
 
it. You may be exposed to it in the environment by breathing, eating,
 
or drinking substances containing the radioactive chemical or from skin
 
contact with it. Exposure can also occur by being near radioactive
 
chemicals at concentrations that are found at hazardous waste sites or
 
industrial accidents.
 
If you are exposed to a hazardous substance such as radium,
 
several factors will determine whether harmful health effects will occur
 
and what the type and severity of those health effects will be. These
 
factors include the dose (how much), the duration (how long), the route
 
or pathway by which you are exposed (breathing, eating, drinking, or
 
skin contact), the other chemicals to which you are exposed, and your
 
individual characteristics such as age, sex, nutritional status, family
 
traits, life style, and state of health.
 
1.1WHAT IS RADIUM?
 
Radium is a naturally-occurring silvery white radioactive metal
 
that can exist in several forms called isotopes. It is formed when
 
uranium and thorium (two other natural radioactive substances) decay
 
(break down) in the environment. Radium has been found at very low
 
levels in soil, water, rocks, coal, plants, and food. For example, a
 
typical amount might be one picogram of radium per gram of soil or rock.
 
This would be about one part of radium in one trillion (1,000,000,000,000)
 
parts of soil or rock. These levels are not expected to change with time.
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Some of the radiation from radium is constantly being released into
 
the environment. It is this release of radiation that causes concern
 
about the safety of radium and all other radioactive substances. Each
 
isotope of radium releases radiation at its own rate, One isotope,
 
radium-224 for example, releases half of its radiation in about three
 
and a half days; whereas another isotope, radium-226, releases half of
 
its radiation in about 1,600 years.
 
When radium decays it divides into two parts. One part is called
 
radiation, and the second part is called a daughter. The daughter, like
 
radium, is not stable; and it also divides into radiation and another
 
daughter. The dividing continues until a stable, nonradioactive
 
daughter is formed. During the decay process, alpha, beta, and gamma
 
radiations are released. Alpha particles can travel only a short
 
distance and cannot travel through your skin. Beta particles can
 
penetrate through your skin, but they cannot go all the way through your
 
body. Gamma radiation, however, can go all the way through your body.
 
Thus, there are several types of decay products that result from radium
 
decay.
 
More information about the properties and uses of radium is found
 
in Chapters 3, 4, and 5.
 
1.2 HOW MIGHT I BE EXPOSED TO RADIUM?
 
Because radium is present, usually at very low levels, in the
 
surrounding environment, you are always exposed to it and to the small
 
amounts of radiation that it releases to its surroundings. You may be
 
exposed to higher levels of radium if you live in an area where it is
 
released into the air from the burning of coal or other fuels, or if
 
your drinking water is taken from a source that is high in natural
 
radium, such as a deep well, or from a source near a radioactive waste
 
disposal site.
 
Levels of radium in public drinking water are usually less than one
 
picocurie per liter of water (about one quart), although higher levels
 
(more than 5 picocuries per liter) have been found. A picocurie (pCi)
 
is a very small amount of radioactivity, and it is associated with about
 
a trillionth of a gram (a picogram) of radium. (There are approximately
 
28 grams in an ounce.) No information is available about the amounts of
 
radium that are generally present in food and air. You may also be
 
exposed to higher levels of radium if you work in a uranium mine or in a
 
plant that processes uranium ores.
 
You will find more information on how you can be exposed to radium
 
in Chapter 5.
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1.3 HOW CAN RADIUM ENTER AND LEAVE MY BODY?
 
Radium can enter the body when it is breathed in or swallowed. It
 
is not known if it can be taken in through the skin. If you breathe
 
radium into your lungs, some may remain there for months; but it will
 
gradually enter the blood stream and be carried to all parts of the
 
body, especially the bones. For months after exposure, very small
 
amounts leave the body daily through the feces and urine.
 
If radium is swallowed in water or with food, most of it (about
 
8O%) will promptly leave the body in the feces. The other 20% will
 
enter the blood stream and be carried to all parts of the body,
 
especially the bones. Some of this radium will then be excreted in the
 
feces and urine on a daily basis.
 
You will find more information on this subject in Chapter 2.
 
1.4 HOW CAN RADIUM AFFECT MY HEALTH?
 
There is no clear evidence that long-term exposure to radium at the
 
levels that are normally present in the environment (for example, 1 pCi
 
of radium per gram of soil) is likely to result in harmful health
 
effects. However, exposure to higher levels of radium over a long
 
period of time may result in harmful effects including anemia,
 
cataracts, fractured teeth, cancer (especially bone cancer), and death.
 
Some of these effects may take years to develop and are mostly due to
 
gamma radiation. Radium gives off gamma radiation, which can travel
 
fairly long distances through air. Therefore, just being near radium at
 
the high levels that may be found at some hazardous waste sites may be
 
dangerous to your health.
 
More information on this subject is presented in Chapter 2.
 
1.5 WHAT LEVELS OF EXPOSURE HAVE RESULTED IN HARMFUL HEALTH EFFECTS?
 
Radium has been shown to cause adverse health effects such as
 
anemia, cataracts, fractured teeth, cancer and death. As shown in
 
Tables l-l through l-4, the relationship between the amount of radium
 
that you are exposed to and the amount of time necessary to produce
 
these effects is not known. Although there is some uncertainty as to
 
how much exposure to radium increases your chances of developing a
 
harmful health effect, the greater the total amount of your exposure to
 
radium, the more likely you are to develop one of these diseases. More
 
information on this subject is presented in Chapter 2.
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1.6 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED
 
TO RADIUM?
 
There are few medical tests to determine if you have been exposed
 
to radium. There is a urine test to determine if you have been exposed
 
to a source of radioactivity such as radium. There is also a test to
 
measure the amount of radon, a breakdown product of radium, when it is
 
exhaled. These tests require special equipment and cannot be done in a
 
doctor's office. Another test can measure the total amount of
 
radioactivity in the body; however, this test is not used except in
 
special cases of high exposure.
 
More information on the methods used to determine levels of
 
exposure to radioactivity can be found in Chapters 2 and 6.
 
1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT
 
HUMAN HEALTH?
 
The Environmental Protection Agency (EPA) regulates the amount of
 
radium in drinking water so that it will not contain more than 5 pCi of
 
combined radium-226 and radium-228 per liter of water. The amount of
 
radioactivity from all sources that is allowed in drinking water and the
 
amount that workers may be exposed to in nuclear plants is regulated.
 
1.8 WHERE CAN I GET MORE INFORMATION?
 
If you have any more questions or concerns not covered here, please
 
contact your State Health or Environmental Department or:
 
Agency for Toxic Substances and Disease Registry
 
Division of Toxicology
 
1600 Clifton Road, E-29
 
Atlanta, Georgia 30333
 
This agency can also give you information on the location of the
 
nearest occupational and environmental health clinics. Such clinics
 
specialize in recognizing, evaluating, and treating illnesses that
 
result from exposure to hazardous substances.
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2. HEALTH EFFECTS
 
2.1 INTRODUCTION
 
This chapter contains descriptions and evaluations of studies and
 
interpretation of data on the health effects associated with exposure to
 
radium. Its purpose is to present levels of significant exposure for
 
radium based on toxicological studies, epidemiological investigations,
 
and environmental exposure data. This information is presented to
 
provide public health officials, physicians, toxicologists, and other
 
interested individuals and groups with an overall perspective of the
 
toxicology of radium and a depiction of significant exposure levels
 
associated with various adverse health effects.
 
It is important to note that in the various studies reviewed in the
 
preparation of this document, dose levels have been presented by those
 
authors in several ways. In order to facilitate comparisons among
 
studies, these levels have generally been converted to an equivalent
 
dose in microcuries (µCi) and kilo-Becquerels (kBq). The historical 
definition of one curie is the disintegration rate exhibited by one gram 
of radium. There are 0.027 µCi per kBq. In this document, comparisons 
are usually made between total administered amounts of radioactivity, in 
µCi/kg and kBq/kg, instead of using a daily dosage level. 
In the case of radium, as well as any radionuclide, it is important
 
to note that, in addition to the usual routes of exposure that must be
 
considered (inhalation, oral, dermal, and occasionally parenteral) for
 
toxic chemicals, there is also external and internal exposure to
 
emissions of alpha and beta particles and gamma rays; and it is these
 
radioactive emissions which are considered to be responsible for most of
 
the biologically deleterious effects observed in exposed persons.
 
Further information about radionuclides is presented in Appendix B.
 
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
 
To help public health professionals address the needs of persons
 
living or working near hazardous waste sites, the data in this section
 
are organized first by route of exposure -- inhalation, oral, and dermal
 
-- and then by health effect -- death, systemic, immunological,
 
neurological, developmental, reproductive, genotoxic, and carcinogenic
 
effects. These data are discussed in terms of three exposure periods -­
acute, intermediate, and chronic.
 
2.2.1 Inhalation Exposure
 
Early workers using radium undoubtedly inhaled microscopic
 
particles of the salts of radium as well as the daughter products
 
resulting from their decay, as they worked with these compounds.
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Therefore, they must have been continually exposed to alpha and beta
 
particles as well as to the intense penetrating gamma radiation emitted
 
by radium and its daughter products, including radon. Thus, any
 
resulting health effects cannot be attributed to a specific cause but
 
were probably the consequence of a combination of all the radiation
 
insults to that individual.
 
2.2.1.1 Death
 
No information has been located regarding the lethal effects of
 
acute exposure to radium via inhalation.
 
An early case study described a 36-year-old chemist who had worked
 
with radium for 14 years and then suddenly developed acute leukopenia
 
and died of bronchopneumonia within a month after the onset (Reitter and
 
Martland 1926). Autopsy data indicated that 14 PCi of radioactive
 
material, including radium and mesothorium (radium-228), was found in
 
the body, but the observation that 1 µci was found in the lungs (as
 
compared with other internal organs such as the liver, gastrointestinal
 
tract, heart, and kidneys which had no measurable levels of
 
radioactivity) convinced the authors that inhalation was the primary
 
route by which radium had entered the body. Most of the radioactivity
 
was found in the skeleton.
 
No studies were located regarding lethality in animals after
 
inhalation exposure to radium.
 
2.2.1.2 Systemic Effects
 
No studies were located regarding systemic effects in humans or
 
animals after inhalation exposure to radium.
 
2.2.1.3 Immunological Effects
 
Acute leukopenia, with almost total absence of granular leukocytes,
 
leukoblastic groups and lymphoid tissue in the bone marrow, was reported
 
in the case of a 36-year-old chemist who had worked with radium for
 
14 years (Reitter and Martland 1926).
 
No studies were located regarding the following health effects in
 
humans or animals after inhalation exposure to radium:
 
2.2.1.4 Neurological Effects
 
2.2.1.5 Developmental Effects
 
2.2.1.6 Reproductive Effects
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2.2.1.7 Genotoxic Effects
 
2.2.1.8 Cancer
 
2.2.2 Oral Exposure
 
It is important to note that effects observed after the ingestion
 
of radium may be attributed not only to radium itself, but to the
 
presence of any or all of its daughter products produced in vivo and
 
their radioactive emissions.
 
2.2.2.1 Death
 
There is no information on the lethal effects of radium due to
 
acute oral exposure. Many deaths, especially from bone cancer, have
 
occurred in humans following long-term oral exposure to radium-226 and
 
radium-228. As described by Rowland et al. (1978), female radium dial
 
painters in the 1920s who "tipped" their paint brushes with their lips
 
or tongues ingested radium in the process. The dial paint usually
 
contained long-lived radium-226 and shorter-lived radium-228. A
 
toxicity ratio has been developed for these isotopes; it has been
 
estimated that radium-228 is about 2.5 times as effective, per µCi, in 
inducing bone sarcomas as radium-226 (Lloyd et al. 1986; Rowland et al. 
1978; Rundo et al. 1986). For various other effects, estimates of the 
effectiveness of radium-228 relative to radium-226 have ranged from zero 
to six (Rundo et al. 1986). Estimated systemic intakes for these 
workers and other exposed persons are listed in the Argonne National 
Laboratory case tables (Gustafson and Stehney 1985). These estimates 
are extrapolations based on body radium content at the time of 
examination (whether from living subjects or exhumed remains), modified 
by the Norris retention function (Norris et al. 1955) to account for the 
decrease in body radium content since exposure, and the known or 
presumed ratios of these isotopes in the materials to which these 
persons were exposed (Rundo et al. 1986). Radium dose levels have been 
expressed as: effective systemic radium intake = (µCi radium-226) + 
2.5 x (µCi radium-228). 
Some of the radium dial painters ingested amounts of radium
 
sufficient to cause death within a few years of their employment.
 
Martland (1931) described the cases of 18 dial painters who died of
 
cancer at ages 20 to 54 years old. Causes of death were listed as
 
anemia, necrosis of the jaw, and osteogenic sarcoma. The typical period
 
of exposure was about two years.
 
Radium was also used as a "rejuvenating" tonic in the 1920s and was
 
available to the general public in bottled water. Gettler and Norris
 
(1933) described a case of a 52-year-old man who drank about 1,400
 
bottles of "Radithor", containing radium at 2 µg/60 ml bottle, over a 
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5-year period (total dose: approximately 2,800 µCi or 56 µCi/kg or 
2,074 kBq/kg for a 50-kg man). The cause of death was stated to be a 
combination of necrosis of the jaw, abscess of the brain, secondary 
anemia and terminal bronchopneumonia. However, it is important to note 
that each of these effects can also be attributed to other etiologies. 
No studies were located regarding lethality in animals after oral
 
exposure to any of the isotopes of radium.
 
2.2.2.2 Systemic Effects
 
Based on case studies of radium dial painters, Martland (1931)
 
stated that anemia, regenerative anemia, aregenerative anemia, or
 
pernicious anemia was listed on the death certificates of ten of 18
 
persons autopsied as part of this study. The bases of these diagnoses
 
(e.g., clinical impressions of the cadaver, laboratory findings, etc.)
 
were not clearly stated. Sharpe (1974) analyzed detailed hematological
 
data relating to dial painters as well as to persons exposed to radium
 
in other ways (eg., male laborers and equipment operators in radiumrelated
 
industries). He concluded, however, that there were no
 
consistent differences in hematological indices between the radiumexposed
 
patients and closely matched controls. From the limited
 
available data, it is difficult to determine if hematological effects
 
are a concern for humans exposed to radium.
 
No studies were located regarding hematological effects in animals
 
after oral exposure to radium.
 
No studies were located regarding the following health effects in
 
humans or animals following oral exposure to radium.
 
2.2.2.3 Immunological Effects
 
2.2.2.4 Neurological Effects
 
2.2.2.5 Developmental Effects
 
2.2.2.6 Reproductive Effects
 
2.2.2.7 Genotoxic Effects
 
2.2.2.8 Cancer
 
The Center for Human Radiobiology at the Argonne National
 
Laboratory has been conducting a surveillance program to identify
 
persons exposed to radium and to determine the details of their
 
exposure, in some cases through exhumation of their remains (Gustafson
 
and Stehney 1985). Based on their findings, bone sarcomas, carcinomas
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of the perinasal sinuses and mastoid air cells (often called head
 
cancers), and deterioration of skeletal tissue are considered to be the
 
only effects that are unequivocally attributable to internal radium
 
(Rundo et al. 1986).
 
These bone sarcomas and head carcinomas have been seen in many
 
radium dial painters and have appeared from 5 to more than 50 years
 
after first exposure to radium. Of those dial painters for whom radium
 
intakes have been estimated (a total of 1,907), 41 have developed bone
 
sarcomas, 16 developed head carcinomas, and an additional 3 cases
 
developed both types. Among dial painters whose radium intakes were not
 
estimated (a total of 2,928), 20 cases with bone sarcomas and 5 with
 
head carcinomas were identified. Thus 85 out of 4,835 known dial
 
painters developed a malignancy as a consequence of their oral ingestion
 
of radium (Rundo et al. 1986).
 
Based on data on these dial painters from the 1985 listing of
 
radium cases studied at the Argonne National Laboratory (Gustafson and
 
Stehney 1985) Rundo et al. (1986) have estimated that the lowest total
 
intake level of radium associated with a malignancy was 60 µCi 
(2,222 kBq) or 1.03 µCi/kg (38 kBq/kg) based on an estimated 58 kg body 
weight for a woman. These estimates are based on current radium body 
content modified by the Norris retention function (to account for the 
decrease in body radium content with time since exposure) and an 
estimate of radium-228 from measurements of radium-226 and the known or 
presumed ratios of these isotopes in the materials to which these 
persons were exposed (Rundo et al. 1986). 
Osteogenic sarcomas were reported in 3 out of 5 rats administered 
radium for 20 days by dropper (Evans et al. 1944). Each animal was 
given a different estimated total dose ranging from 10 to 70 µCi. The 
lowest dose to clearly induce a malignancy was 22 µCi (approximately 
73 µCi/kg or 2,703 kBq/kg). 
2.2.3 Dermal Exposure
 
No studies were located regarding the following health effects in
 
humans or animals after dermal exposure to radium.
 
It is important to note, however, that the radium dial painters had
 
chronic dermal exposure to radium on their lips and tongues. Although
 
no recognition of this fact has been located in the literature, it is
 
noteworthy that no local effects on exposed skin have been described in
 
the available case studies of these workers (eg., Martland 1931; Sharpe
 
1974).
 
2.2.3.1 Death
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2.2.3.2 Systemic Effects
 
2.2.3.3 Immunological Effects
 
2.2.3.4 Neurological Effects
 
2.2.3.5 Developmental Effects
 
2.2.3.6 Reproductive Effects
 
2.2.3.7 Genotoxic Effects
 
2.2.3.8 Cancer
 
2.2.4 Other Routes of Exposure
 
While parenteral exposure is not a route posing a significant
 
environmental threat to human health from the isotopes of radium, data
 
acquired in studies using this route are presented here because
 
thousands of persons did acquire radium via this route, and most of the
 
toxicity and metabolic studies with experimental animals have used this
 
route. It is again important to note that effects observed after
 
parenteral administration of radium may be attributed not only to radium
 
itself, but to the presence of any or all of its daughter products and
 
their radioactive emissions in vivo.
 
In the years after World War II (1946 to 1950), repeated injections
 
of radium-224 were given to adults and children in Germany for treatment
 
of tuberculosis, ankylosing spondylitis, and other diseases. Out of
 
about 2,000 persons who received this treatment, 816 of these cases are
 
currently being followed (Spiess et al. 1978). Of the 816, 204 were
 
injected as juveniles (ages 1 to 20 years) and 612 as adults. The
 
average total injected activity was 18 µCi/kg (666 kBq/kg) (Mays et al. 
1985a). 
A second study of persons injected with radium-224 in Germany from
 
1948 to 1975 included 1,473 ankylosing spondylitis patients who were
 
also treated with repeated intravenous injections of radium, but at
 
lower levels. They typically received a series of 10 to 12 injections
 
at weekly intervals, each containing 28 µCi (1,037 kBq). Some patients 
received two or three such series, and one patient received four. The 
average total injected activity was 4.8 µCi/kg (178 kBq/kg) (Wick and 
Gossner 1983, 1989). 
Pure radium-226 was given intravenously as a medication in the
 
United States from the time it first became available until the mid­
1930s. Treatment of patients at the Elgin State Hospital in Illinois
 
was described by Schlundt et al. (1933), where from 1931 to 1933,
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32 patients were given 10 µCi (370 kBq) injections, usually weekly, for 
periods ranging from about 2 to 6 months. In the 195Os, these patients 
were located, their radium body content was measured, and their health 
status was subsequently followed (Norris et al. 1955). 
2.2.4.1 Death
 
No studies were located regarding acute lethality in humans
 
following parenteral administration of radium isotopes. Early uses of
 
radium-226 by physicians (usually as a treatment for arthritis) involved
 
intravenous injections as large as 1 mg (1,000 µCi or 37,037 kBq) of 
elemental radium (thus approximately 14 µCi /kg or 518 kBq/kg), which 
were claimed to have no ill effects (Proescher 1914). As described in 
Section 2.2.4.8, patients receiving injections of radium have developed 
cancer which has resulted in death. 
Injection of mice with radium (presumably radium-226) at 2,000 to 
4,000 µCi/kg (74,000 to 148,000 kBq/kg) was fatal in 7 to 10 days 
(Proescher and Almquest 1914); however, experimental details were not 
provided. In 12-week-old mice given a single intraperitoneal injection 
of radium-224 or a series of 8 such injections over a period of 4 weeks, 
there was no evidence of a decrease in life span at any level, up to the 
maximum tested, approximately 60 µCi /kg (2,220 kBq/kg) (Humphreys et al. 
1985).
 
2.2.4.2 Systemic Effects
 
No studies have been located regarding respiratory, cardiovascular,
 
gastrointestinal, musculoskeletal, renal, or dermal effects in humans or
 
animals after parenteral administration of radium.
 
Hematological Effects. In a follow-up study of the second group of 
German patients who had received repeated intravenous injections of 
radium-224, the injected doses averaged 4.8 µCi/kg (178 kBq/kg) total 
exposure (Wick and Gossner 1983; Wick et al. 1986) for 1,501 patients. 
Ten cases of bone marrow failure were observed in these patients, as 
compared with 7 cases in the controls (1,338 similar patients not 
treated with radiation) (Wick and Gossner 1989). The statistical 
significance of these findings was not addressed. 
In the bone marrow of mice given intraperitoneal injections of 
radium-226 at 17,820 µCi/kg (660,000 kBq/kg), there was a depression in 
the number of hemopoietic stem cells which lasted until at least 
100 days after the injection but returned to normal by 300 days 
(Schoeters and Vanderborght 1981). Schoeters et al. (1983) reported a 
marked depression in the number of peripheral white blood cells of mice 
at 400 days after a 670 µCi (24,800 kBq) intraperitoneal injection of 
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the chloride salt of radium-226 (approximately 22,320 µCi /kg or 
827,000 kBq/kg). At 530 days post-injection, these levels appeared to 
be recovering. There were no consistent trends in the peripheral white 
blood cell levels of the lower dose groups (3,960 and 10,000 µCi/kg or 
147,000 and 370,000 kBq/kg). 
Hepatic Effects. Chronic liver diseases, mostly cirrhosis, were
 
reported in 20 cases (out of 682 adults and 218 children) who were
 
followed for an average of 20 years after repeated injections of radium­
224 totaling an average of 18 µCi/kg (667 kBq/kg). Eighteen of these 
patients were injected as adult men, one as an adult woman, and one as a 
juvenile. The authors suggested that this is a radiation effect; 
however, statistical significance was not addressed and the total 
incidence in this group (2.2%) may have been comparable to that of the 
general population. The higher incidence in men was thought to be 
related to their higher exposure to liver toxins such as alcohol or 
industrial chemicals (Spiess and Mays 1979). 
Ocular Effects. Cataracts were reported in 6% (12/218) of patients
 
injected with radium-224 as children. The known dosages averaged
 
28 µCi/kg (1,037 kBq/kg). Of these cases with known doses, 14% (11/80) 
had cataracts after receiving more than 28 µCi/kg (1,037 kBq/kg), 
whereas only 0.8% (l/131) developed cataracts after receiving less than 
that dose (Stefani et al. 1985). The younger patients received the 
highest doses in µCi/kg in this study, and thus, presumably, the highest 
radiation dose to the eye. The lowest dose known to be associated with 
a cataract that developed after a radium-224 treatment in childhood was 
15.6 µCi/kg (577 kBq/kg) given to a 4.5 year-old-girl (Chmelevsky et al. 
1988a). 
In beagle dogs, intravenously injected radium-226 was deposited in
 
the melanin granules of pigmented cells and rodlike organelles of the
 
tapetum in the eye (a structure that humans do not have). Retention in
 
the eye varied inversely with dose. At doses from 0.062 to 1.1 µCi/kg 
(2.3 to 41 kBq/kg), 1oss of pigment at the higher doses and melanosis
 
and intraocular melanoma formation at the lower doses were observed
 
(Taylor et al. 1972).
 
Other Systemic Effects. Radiation damage to dental tissue, or
 
perhaps to its blood supply, initiates extensive resorption of the
 
dentine, especially at the gum line. These radiation-induced caries
 
weaken teeth and cause them to fracture easily. Such tooth breakage has
 
been reported in 12% (27/218) of patients injected with radium-224 as
 
children (20 years old and younger) and by 2% (17/681) of patients
 
injected as adults (21 years old and older). The highest incidence
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occurred in adolescents injected at 16 to 20 years of age (15/61 or
 
25%). Combining results from all age groups, the incidence of tooth
 
fracture increased significantly with dose (p=0.01) (Sonnabend et al.
 
1986).
 
2.2.4.3 Immunological Effects

 No studies were located regarding immunological effects in humans
 
after parenteral exposure to radium.
 
A marked decrease was found in the number of peripheral white blood
 
cells of mice at 400 days after an intraperitoneal injection of the 
chloride salt of radium-226 at about 22,320 µCi/kg (827,000 kBq/kg) 
(Schoeters et al. 1983). These results suggest that compromised immune 
function may be a concern for humans exposed to radium. 
2.2.4.4 Neurological Effects
 
No studies were located regarding neurological effects in humans or
 
animals after parenteral exposure to radium.
 
2.2.4.5 Developmental Effects
 
In a follow-up study of the first group of German patients injected
 
with radium-224 as therapy for tuberculosis when they were children (see
 
Section 2.2.4), it was found that the adult heights of these persons
 
were markedly lower than the heights of nontreated persons. This effect
 
was attributed to the formation of overcalcified "growth arrest plates"
 
during the radium-224 injections. The reduction was greatest for those
 
individuals who were the youngest at the age of injection; however, the
 
youngest children were given the highest doses of injected radium-224 in
 
µCi/kg (Spiess et al. 1985). The authors could not determine if this 
effect has a threshold but stated that the continued slowing of the 
growth rate long after irradiation suggests that some growth retardation 
may occur at very low doses of radium. 
2.2.4.6 Reproductive Effects
 
No studies were located regarding reproductive effects in humans or
 
animals following parenteral exposure to radium.
 
2.2.4.7 Genotoxic Effects
 
No studies were located regarding genotoxic effects in humans or
 
animals following parenteral exposure to radium.
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2.2.4.8 Cancer
 
Bone tumors, primarily osteogenic sarcomas, have appeared in the
 
first group of German patients injected with radium-224 (see
 
Section 2.2.4) (Spiess et al. 1989). A total of 56 sarcomas have been
 
found; the expected number is 0.2 to 0.3 (Spiess et al. 1989). The
 
lowest total dose associated with a bone tumor was 6.4 µCi/kg 
(237 kBq/kg) given over two months (Mays and Spiess 1984). 
An elevated incidence of breast cancer has also been observed in
 
the female patients in this group (14 cases versus 4.1 to 6.1 expected).
 
Eight of these cases occurred among those injected as children, whereas
 
only 0.6 to 0.9 were expected. In patients injected as adults, the 6
 
observed cases are not significantly different from the 3.5 to 5.2 cases
 
expected (Spiess et al. 1989). This suggests that exposure to
 
radium-224 during childhood poses a much greater risk for the induction
 
of breast tumors than does exposure as an adult.
 
An elevated incidence of liver cancer has been seen in the first
 
series of German patients (6 versus 1.1 to 1.2 expected). Five cases of
 
kidney cancer have also been observed, compared with 2.4 to 2.6 expected
 
(Spiess et al. 1989); however, this increase is not statistically
 
significant. The authors suggest that these cancers may also have been
 
induced by the radium-224.
 
In the second group of German patients treated with radium-224 (see
 
Section 2.2.4), at lower injected doses, three malignant tumors in the
 
skeleton have been observed (versus 0.4 to 0.7 expected); two were
 
tumors of the bone marrow (a reticulum cell sarcoma and a plasmocytoma)
 
and one was a fibrosarcoma (Wick and Gossner 1989). One skeletal tumor,
 
a plasmocytoma, was observed among the controls, a group of 1,338
 
ankylosing spondylitis patients who were not treated with radiation
 
(Wick and Gossner 1989).
 
Of the Elgin State Hospital patients who received injections of
 
radium-226 (see Section 2.2.4), two patients developed bone sarcomas,
 
four developed head carcinomas, and a seventh patient had both types of
 
malignancy (statistical significance was not addressed) (Gustafson and
 
Stehney 1985).
 
Large experimental animal studies with parenterally administered
 
radium, primarily using dogs, but some using rats and mice, have
 
demonstrated that radium-224, radium-226, and radium-228 can induce bone
 
cancers and leukemias in these species (Evans et al. 1944; Humphreys
 
et al. 1985; Kofranek et al. 1985; Mays et al. 1987; Taylor et al.
 
1983). However, head carcinomas, such as those found in humans, were
 
not found in any of the species tested, indicating that this malignancy
 
was not induced under the conditions of these animal studies. The most
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unexpected finding was the induction of intraocular melanomas in beagles
 
by radium-226 by Taylor et al. (1972). These tumors have not been seen
 
in any of the human studies.
 
2.3 TOXICOKINETICS
 
In radiation biology, the term "dose" has a specific meaning. Dose
 
refers to the amount of radiation absorbed by the organ or tissue of
 
interest per unit mass and is expressed in rads (grays). Estimation of
 
this radiation dose is sometimes accomplished by modeling the sequence
 
of events involved in the acquisition, deposition, clearance, and decay
 
of radium within the body. While based on the current understanding of
 
experimental data on radium toxicokinetics, different models make
 
different assumptions about these processes, thereby resulting in
 
different estimates of dose and risk. These models are described in
 
numerous reports including BEIR IV (1988), ICRP (1979), and Raabe et al.
 
(1983). In this section, the toxicokinetics of radium are described
 
based on the available experimental data rather than on descriptions
 
derived from models.
 
2.3.1 Absorption
 
2.3.1.1 Inhalation Exposure
 
The only study located on human absorption of radium after
 
inhalation exposure involved the accidental rupture of capsules
 
containing radium sulfate (presumed to be primarily radium-226), with
 
the resultant brief exposure of several laboratory workers (Marinelli
 
et al. 1953). Radium was deposited both in the lungs and the skeletons
 
of these individuals, indicating that some of the radium absorbed by the
 
lung had entered the systemic circulation, ultimately depositing in the
 
bones. Some of the radium, however, may have been coughed up and then
 
swallowed during the original exposure and then entered the systemic
 
circulation after being absorbed by the gut. The average half-life of
 
the decrease of gamma ray activity from the thorax was reported to be
 
about 120 days. The possibility of dermal exposure and consequent
 
absorption during this episode was not addressed.
 
No studies were located regarding the absorption of radium in
 
animals after inhalation exposure.
 
2.3.1.2 Oral Exposure
 
Based on a study of elderly human subjects (aged 63 to 83 years)
 
who ingested mock radium dial paint containing 224RaS4, Maletskos et al.
 
(1966, 1969) have estimated that about 80% of the ingested radium was
 
promptly excreted via the feces during the first 10 days, and about 20%
 
was retained and distributed systemically. The feces to urine excretion
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ratios remained high (about 30:1) during another phase of this study in
 
which similar subjects were given intravenous injections of radium-224.
 
This suggested that biliary excretion is probably involved and that
 
perhaps more than the estimated 20% of ingested radium was actually
 
absorbed. However, this topic was not addressed in the study.
 
Measurements of body radium acquired by adult and teenage males
 
solely from natural levels of radium in food and water indicated that
 
approximately twice the amount of ingested radium was retained by
 
younger males from one location, Lockport, Illinois (mean age:
 
16.6 years) than by older males in a penitentiary in Stateville,
 
Illinois (means of age groups: 27, 38 and 44 years) (Stehney and Lucas
 
1955). Among the prisoners, mean body radium content was increased with
 
the mean age of the men. However, boys from another location, Chicago,
 
Illinois (mean age: 16.6 years) had similar radium body contents to
 
that of the single Chicago adult man participating in this study. The
 
results of this study also suggested that the absorption of radium from
 
water was greater than that from food, based on excretion rates measured
 
in areas where either food or water was the predominant source of
 
radium. The authors acknowledged that these were speculations and not
 
clearly supportable by the results of their limited study.
 
In rats, the absorption of orally administered radium may be quite
 
low. At 400 to 500 days after administration, they retained 1 to 7% of
 
the ingested radium, primarily in the skeleton. In contrast, rats
 
intradermally injected with radium retained 77% of the administered
 
radium at 140 to 300 days after injection (Evans et al. 1944).
 
Differences seen in the results of these two studies could reflect
 
differences in time frame and/or the route of administration. The
 
probable influence of biliary excretion of orally administered radium
 
and the possibly slow rate of absorption of intradermally administered
 
radium from the site of injection may help account for these
 
differences.
 
2.3.1.3 Dermal Exposure
 
No studies were located regarding the absorption of radium in
 
humans or animals after dermal exposure.
 
2.3.2 Distribution
 
2.3.2.1 Inhalation Exposure
 
Based on the observations of Marinelli et al. (1953), immediately
 
after accidental exposure of humans to radium-226 (as the sulfate), the
 
major deposit of radium was in the lungs. This deposition decreased
 
with an average half-life of 118 days (±30 days). Elimination from the
 
lungs via the systemic circulation results in a continuous deposition in
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the skeleton as well as distribution to soft tissue and the excretory
 
system. In addition, some of the radium salt may have been coughed up
 
and swallowed during the exposure episode.
 
It is assumed that radium that has been deposited in the lung as a
 
radium salt enters the systemic circulation either as that salt or as
 
individual radium atoms at a rate dependent upon the solubility and
 
chemical characteristics of the specific radium salt involved.
 
Subsequently, these salts or radium atoms would be systemically
 
transported in the same manner as radium acquired by oral or parenteral
 
administration. However, some of the radium in the lung could be
 
retained for a long time before this process is completed. The ultimate
 
distribution, many years after an inhalation exposure, would probably be
 
very similar to that of other routes of administration; that is, most of
 
the radium that was retained in the body would eventually be deposited
 
in the skeleton (Marinelli et al. 1953).
 
2.3.2.2 Oral Exposure
 
No studies have been located that specifically follow the
 
distribution of radium in humans or animals following oral exposure.
 
Distribution to the skeleton is assumed due to the findings of
 
osteosarcomas in the dial painter studies as well as the presence of
 
radium in their exhumed skeletal remains. The affinity for bone is
 
assumed to be related to its similarity to calcium (BIER IV 1988).
 
2.3.2.3 Dermal Exposure
 
No studies were located regarding the distribution of radium in
 
humans or animals following dermal exposure.
 
2.3.2.4 Other Routes of Exposure
 
Parenteral administration of radium to humans results in short-term
 
distribution to soft tissue which is rapidly followed by deposition of
 
most of the radium in the skeleton (BEIR IV 1988).
 
Radium, similarly to calcium, deposits in bone within those areas
 
where new bone mineral is being formed and also on all bone surfaces.
 
Radium remains in those areas of new bone formation, but the radium
 
deposits on bone surfaces eventually move into the depths of compact
 
bone as new bone matrix is deposited on top of them. In this deposition
 
process, short-lived radium-224 rapidly decays, leaving no radioactivity
 
within bone; whereas, long-lived radium-226 remains in the skeleton
 
indefinitely (Rowland 1966). Mays et al. (1975) have demonstrated that
 
the radon to radium ratio in bone increased with time after injection in
 
beagles.
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Injected radium is deposited in the eye of the dog (Taylor et al.
 
1972) and to some extent in the human eye (Chmelevsky et al. 1988a).
 
2.3.3 Metabolism
 
Radium is an element and cannot be metabolized. In biological
 
systems in which radium salts are deposited, these compounds will
 
dissociate based on their solubility in that media. Radioactive decay
 
of the radium cation occurs over time.
 
2.3.4 Excretion
 
2.3.4.1 Inhalation Exposure
 
Based on a study of persons exposed to radium-226 during an
 
industrial accident which involved the rupture of a capsule containing
 
the insoluble salt radium sulfate (Marinelli et al. 1953), the excretion
 
of radium occurred in two phases. In the initial phase, 2 to 4% of the
 
estimated total body burden was excreted in the urine over a few days
 
and was attributed to the elimination of radium ingested during the
 
incident (due to the coughing up and swallowing of ingested radium).
 
(Fecal excretion was not monitored.) In the second phase, about
 
100 days after the exposure, the urinary excretion rate was higher than
 
predicted from the authors calculations (based on retention/excretion
 
models on dogs injected with radium chloride). This phase was
 
attributed to the presence of more radium in circulation than expected
 
as a consequence of a continual release of radium sulfate from the lung.
 
2.3.4.2 Oral Exposure
 
Following oral exposure to radium, excretion occurs in two phases.
 
In the first phase, approximately 80% of the ingested radium is rapidly
 
eliminated through the feces. In the slower second phase, most of the
 
20% that was absorbed into systemic circulation, is ultimately excreted
 
from the body via the feces (Maletskos et al. 1966, 1969). These
 
observations suggest that biliary excretion is probably involved;
 
however, no information has been located on that topic.
 
2.3.4.3 Dermal Exposure
 
No studies were located regarding the excretion of radium in humans
 
or animals after dermal exposure.
 
2.3.4.4 Other Routes of Exposure
 
Following intravenous administration of radium-224 to elderly human
 
subjects (63 to 83 years), the excretion of radium was primarily via the
 
feces, with fecal to urinary ratios of about 30-to-1 usually observed
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(Maletskos et al. 1966, 1969). Although these observations suggest that
 
biliary excretion is involved, no data are available to verify that
 
assumption. The whole body retention was about 15% after 20 days.
 
The excretion of parenterally acquired radium from the human body
 
occurs in two phases; the first phase is very rapid, but the small
 
fraction that remains in the body is ultimately released very slowly,
 
presumably due to the turnover of bone matrix. An equation to describe
 
the retention of radium in the human body, derived by Norris et al.
 
(1955), predicts that the retention of radium 10 days after acquisition
 
will be 16%, dropping to 2.5% at 1 year, 0.76% at 10 years, and 0.43% at
 
30 years. A similar equation has been developed for dogs.
 
Seil et al. (1915) studied the excretion pattern of radium that had
 
been subcutaneously injected as the chloride salt into two dogs. The
 
resulting measurements varied widely over the next few days; however, it
 
was clear that there was a rapid initial elimination of radium in the
 
feces and that fecal to urinary excretion ratios were typically about
 
10-to-l.
 
In a study in dogs, it was shown that long-term retention of radium
 
is dependent upon age at injection, with younger dogs (3 months old)
 
that were still undergoing skeletal growth retaining more of the
 
injected activity than older dogs (18 months to 2 years old). However,
 
very young dogs (2 to 5 days old), undergoing major skeletal growth and
 
changes in bone shape lost most of their injected radium in the course
 
of these processes (Bruenger et al. 1983).
 
2.4 RELEVANCE TO PUBLIC HEALTH
 
Death. Death and decreased longevity have been reported in persons
 
who have had long-term exposure (approximately one or more years) to
 
radium. A 52-year-old man died following 5 years of consumption of
 
about 1,400 bottles of water containing radium at 2 µg per bottle, 
resulting in the total ingestion of approximately 2,800 µCi or 56 µCi/kg 
(2,074 kBq/kg) for a 50-kg man (Gettler and Norris 1933). However, the 
causes of death (jaw necrosis, brain absess, secondary anemia, and 
bronchopneumonia) can also be attributed to other etiologies. Case 
studies of women who died following ingestion of radium in dial paint 
were reported by Martland (1931). Deaths were attributed to anemia, 
necrosis of the jaw, and osteogenic sarcomas. A typical exposure 
duration was about two years. A 36-year-old chemist who had worked with 
radium for 14 years died of bronchopneumonia (Reitter and Martland 
1926). Autopsy results suggested to the authors that inhalation was the 
main route of radium intake. 
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No deaths of patients (being treated mostly for arthritis) were 
reported to result from intravenous injections of radium at amounts up 
to 1,000 µCi or 14 µCi/kg (518 kBq/kg) (Proescher 1914). However, these 
patients may not have been followed clinically for more than a few 
months after these injections. 
Studies using mice have shown life-shortening effects of
 
intravenously injected radium-226 at high dose levels (2,000 to
 
4,000 µCi/kg or 74,074 to 148,148 kBq/kg) (Proescher and Almquest 1914). 
Injection of mice with radium-224 at lower levels (up to 60 µCi/kg or 
2,222 kBq/kg) did not result in life-shortening effects (Humphreys 
et al. 1985). 
Based on the results in humans and animals, lethality is a major
 
public health concern associated with long-term low-level or short-term
 
high-level exposure to radium. As discussed previously, total
 
cumulative intake appears to be the most important factor in relation to
 
health effects related to radium exposure.
 
Systemic Effects. Diseases of the hematopoietic tissues have been
 
reported in patients given repeated injections of radium-224. Anemia,
 
panmyelophthisis, and chronic myeloid leukemia were seen in excess of
 
the control levels in these cases (compared with a higher incidence of
 
acute leukemia in the control group) (Wick et al. 1986). Anemia has
 
also been reported in case studies of the radium dial painters (Martland
 
1931), but the disease patterns have not been clearly established
 
(Sharpe 1974).
 
Studies with mice injected with radium-226 at 24 µCi/kg 
(889 kBq/kg) have demonstrated reductions in the hemopoietic stem cells 
of the bone marrow for at least 100 days after radium acquisition 
(Schoeters and Vanderborght 1981). 
Ocular effects have not been reported in humans or animals exposed
 
to radium via inhalation, oral, or dermal routes. However, ocular
 
effects have been observed in both humans and animals injected with
 
radium. Cataracts were reported in 6% of the German patients who had
 
been injected with radium-224 as children (Chmelevsky et al. 1988a;
 
Stefani et al. 1985). In contrast, the incidence of cataracts in female
 
dial painters was not correlated with total radium intake or age at
 
first exposure, nor was there a difference in appearance times between
 
high and low total radium intakes (Adams et al. 1983). However, the
 
dial painters were exposed orally, the isotope was mainly radium-226,
 
and very few of these dial painters were exposed when younger than
 
15 years of age. Any of these factors may account for the difference
 
between the results observed in these two studies.
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In beagle dogs, intravenously injected radium-226 resulted in
 
melanosis and intraocular melanoma formation at the lower doses and a
 
loss of pigment at the higher doses (Taylor et al. 1972). In this
 
study, deposition of radium was found in the melanin granules of
 
pigmented cells and rodlike organelles of the tapetum of the eye (a
 
structure that humans do not have). Although this process cannot take
 
place in humans, these results further suggest that the eye may be a
 
target for absorbed radium in exposed humans.
 
Other Systemic Effects. Information on other systemic effects is
 
not available for humans or animals exposed to radium via inhalation,
 
oral, or dermal exposure. However, tooth breakage has been reported to
 
occur in the German patients who were injected with radium-224
 
(Sonnabend et al. 1986). The incidence of these dental fractures was
 
highest (25%) in persons who had been injected at 16 to 20 years of age,
 
as compared with 12% in the total group of persons injected at age
 
20 years and younger, and 2% in persons injected when they were 21 years
 
old and older.
 
Immunological Effects. Evidence of radium's potential effects on
 
the human immune system was presented by Reitter and Martland (1926) in
 
the case study of a chemist who developed acute leukopenia after working
 
with radium for 14 years. Autopsy revealed almost total absence of
 
granular leukocytes, leukoblastic groups, and lymphoid tissue in the
 
bone marrow. Similarly, Martland (1931) described the development of
 
leukopenia in the radium dial painters.
 
Schoeters et al. (1983) showed a reduction in the number of
 
peripheral white blood cells of mice at 400 days after an
 
intraperitoneal injection of radium-226. These observations suggest
 
that immunological effects may be an important area of concern for
 
persons occupationally exposed to radium.
 
Cancer. In humans, radium-224 is known to induce bone sarcomas,
 
and it is strongly suspected of inducing breast cancer in females who
 
received this isotope when younger than 21 years of age at total doses
 
greater than 12 µCi/kg (444 kBq/kg). Liver and kidney cancers are also 
possibly induced by radium-224 (Spiess et al. 1989). 
Bone sarcomas are known to be induced by both radium-226 and
 
radium-228, while carcinomas of the bones enclosing the mastoid air
 
cells and paranasal sinuses are known to be induced by exposure to
 
radium-226. These carcinomas are believed to be caused by radon, a
 
gaseous daughter product of radium-226, which migrates from the location
 
where it was formed and becomes trapped within air cells in these
 
structures. Here the subsequent decay products of radon irradiate the
 
sensitive cells on the surfaces, and this irradiation is thought to
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induce the malignant change. Breast cancer and multiple myeloma were
 
found to be elevated in female dial painters, but these effects may be
 
the consequence of the external radiation from the radioactive paint
 
that was used by these workers (Rowland et al. 1989; Stebbings et al.
 
1984).
 
In Great Britain, radium dial painters with higher total radium-226
 
intakes and who were younger than 30 years of age at the start of
 
painting showed an excess of breast cancers (Baverstock and Papworth
 
1989). External gamma ray exposure to the radioactive paint could also
 
have been the cause of cancer in this population.
 
In experimental animals, bone cancer has been the most prominent
 
consequence of radium incorporation and has been found in all species
 
tested.
 
It should be noted that leukemia, which is often induced in humans
 
by irradiation of marrow cells, has not been observed to occur in excess
 
in the studies of the radium-irradiated populations (i.e., dial
 
painters; patients receiving intravenous injections) above the numbers
 
expected for nonirradiated populations (Baverstock and Papworth 1985;
 
Spiers et al. 1983; Spiess et al. 1989).
 
2.5 BIOMARKERS OF EXPOSURE AND EFFECT
 
Biomarkers are broadly defined as indicators signaling events in
 
biologic systems or samples. They have been classified as markers of
 
exposure, markers of effect, and markers of susceptibility (NAS/NRC
 
1989).
 
A biomarker of exposure is a xenobiotic substance or its
 
metabolite(s) or the product of an interaction between a xenobiotic
 
agent and some target molecule or cell that is measured within a
 
compartment of an organism (NAS/NRC 1989). The preferred biomarkers of
 
exposure are generally the substance itself or substance-specific
 
metabolites in readily obtainable body fluid or excreta. However,
 
several factors can confound the use and interpretation of biomarkers of
 
exposure. The body burden of a substance may be the result of exposures
 
from more than one source. The substance being measured may be a
 
metabolite of another xenobiotic (e.g., high urinary levels of phenol
 
can result from exposure to several different aromatic compounds).
 
Depending on the properties of the substance (e.g., biologic half-life)
 
and environmental conditions (e.g., duration and route of exposure), the
 
substance and all of its metabolites may have left the body by the time
 
biologic samples can be taken. It may be difficult to identify
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individuals exposed to hazardous substances that are commonly found in
 
body tissues and fluids (e.g., essential mineral nutrients such as
 
copper, zinc and selenium). Biomarkers of exposure to radium are
 
discussed in Section 2.5.1.
 
Biomarkers of effect are defined as any measurable biochemical,
 
physiologic, or other alteration within an organism that, depending on
 
magnitude, can be recognized as an established or potential health
 
impairment or disease (NAS/NRC 1989). This definition encompasses
 
biochemical or cellular signals of tissue dysfunction (e.g., increased
 
liver enzyme activity or pathologic changes in female genital epithelial
 
cells), as well as physiologic signs of dysfunction such as increased
 
blood pressure or decreased lung capacity. Note that these markers are
 
often not substance specific. They also may not be directly adverse but
 
can indicate potential health impairment (e.g., DNA adducts).
 
Biomarkers of effects caused by radium are discussed in Section 2.5.2.
 
A biomarker of susceptibility is an indicator of an inherent or
 
acquired limitation of an organism's ability to respond to the challenge
 
of exposure to a specific xenobiotic. It can be an intrinsic genetic or
 
other characteristic or a preexisting disease that results in an
 
increase in absorbed dose, biologically effective dose, or target tissue
 
response. If biomarkers of susceptibility exist, they are discussed in
 
Section 2.7, "POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE."
 
2.5.1 Biomarkers Used to Identify or Quantify Exposure to Radium
 
Exposure to radium can be determined by use of a whole body counter
 
to measure the presence of gamma radiation emitted by radium (Toohey
 
et al. 1983). Radium levels can also be measured in urine, feces, and
 
other biological media by means of gamma-ray spectroscopy (Lloyd et al.
 
1983).
 
2.5.2 Biomarkers Used to Characterize Effects Caused by Radium
 
Humans have not been shown to develop specific adverse effects as a
 
result of exposure to radium. Osteogenic sarcoma and cataracts are
 
associated with radium exposure but can also result from other causes.
 
Similarly, chromosomal aberrations may result from radium exposure as
 
well as from other factors such as cigarette smoking or occupational
 
exposure to solvents.
 
Attempts to correlate the estimated total intake of radium with 
observed health effects, especially bone cancer, have been conducted at 
the Argonne National Laboratory (Gustafson and Stehney 1985). For 
example, Rundo et al. (1986) have estimated that the lowest total intake 
level of radium associated with a malignancy (bone sarcoma) was 60 µCi 
(2,222 kBq) or 1.03 µCi/kg (38 kBq/kg) based on an estimated 58-kg body 
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weight for a woman. If data associated with exposed populations were
 
fully analyzed, levels of radium in human tissue might be a good
 
predictor of at least the potential for developing bone cancer.
 
However, there is expected to be some degree of uncertainty, as in cases
 
of persons with high levels of exposure to radium (such as some of the
 
dial painters, the case of the chemist described by Reitter and Martland
 
and the man who drank 1,400 bottles of "Radithor"), who did not develop
 
bone cancer (Gettler and Norris 1933; Martland 1931; Reitter and
 
Martland 1926).
 
2.6 INTERACTIONS WITH OTHER CHEMICALS
 
No data have been located which evaluate the health effects of
 
radium in any of its isotopic forms in combination with any other
 
chemicals or radionuclides.
 
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
 
The available studies suggest that persons who are exposed to
 
radium during childhood or adolescence may be at greater risk from the
 
potential health effects of radium, especially tooth breakage
 
(Section 2.2.4.2), reduction in bone growth (Section 2.2.4.5), and
 
breast tumors (Section 2.2.4.8). There may also be a subpopulation of
 
humans who are genetically more susceptible to the development of bone
 
cancer (Floyd et al. 1983). Patients with Paget's disease have 10 to
 
100 times the risk of bone sarcoma than the general population.
 
2.8 ADEQUACY OF THE DATABASE
 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of
 
the Public Health Service) to assess whether adequate information on the
 
health effects of radium is available. Where adequate information is
 
not available, ATSDR, in conjunction with the National Toxicology
 
Program (NTP), is required to assure the initiation of a program of
 
research designed to determine these health effects (and techniques for
 
developing methods to determine such health effects) of radium.
 
The following categories of data needs have been identified by a
 
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
 
substance-specific informational needs that, if met would reduce or
 
eliminate the uncertainties of human health assessment. In the future,
 
the identified data needs will be evaluated and prioritized, and a
 
substance-specific research agenda will be proposed.
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2.8.1 Existing Information on the Health Effects of Radium
 
The existing data on health effects of inhalation, oral, and dermal
 
exposure of humans and animals to radium are summarized in Figure 2-l.
 
The purpose of this figure is to illustrate the existing information
 
concerning the health effects of radium. Each dot in the figure
 
indicates that one or more studies provide information associated with
 
that particular effect. The dot does not imply anything about the
 
quality of the study or studies. Gaps in this figure should not be
 
interpreted as "data needs" information.
 
Figure 2-l indicates whether information on the endpoint of a
 
particular health effect is available for a specific route and duration
 
of exposure for radium. Some information was located concerning human
 
inhalation or oral exposure to radium, and no information was located
 
concerning effects following dermal exposure to radium by humans. The
 
only information available for animals is an intermediate-duration study
 
in rats conducted via the oral route that resulted in cancer. There is
 
virtually no information on noncancer endpoints from animal studies. As
 
discussed in previous sections, most available information on radium is
 
the result of studies using parenteral administration.
 
In general, the adverse effects of radium are believed to be the
 
consequence of the radiation emitted from the element itself and its
 
daughter products. Because there is already a considerable amount of
 
information on the effects of radiation on humans and animals deri-ved
 
from studies on the effects of the atomic bomb and of therapeutic x-ray
 
and gamma-ray treatments of malignancies, the experimental animal
 
studies with radium have made no attempt to duplicate this information.
 
They have instead concentrated on radium's most sensitive endpoint,
 
cancer. For example, it can be predicted that the beta and gamma rays
 
emitted by a radium source will produce local radiation burns and tissue
 
damage when the source is placed on human or animal skin, hence there
 
have been no valid reasons to conduct such studies with radium.
 
2.8.2 Identification of Data Needs
 
Acute-Duration Exposure. There is no information available on the
 
effects of acute-duration exposure to radium by humans or animals via
 
inhalation, oral, or dermal exposure. The available toxicokinetic data
 
suggest that radium can be absorbed and retained after inhalation and
 
oral exposure. Although there are some toxicokinetic data that provide
 
information on the retention of inhaled radium sulfate in the lung, it
 
is not clear whether this compound and other salts of radium would
 
remain in the lung long enough after acute-duration exposure to cause
 
local effects such as lung cancer or other carcinogenic or
 
noncarcinogenic systemic effects.
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Animal studies conducted via the inhalation, oral, and dermal routes of
 
exposure for this duration period would be useful since the potential
 
short-term effects of such exposure as well as effects that could emerge
 
years later, such as cancer, are not known.
 
Intermediate-Duration Exposure. There are no data on intermediate-

duration exposure of humans to radium via the inhalation, oral, or
 
dermal routes. There are no data on animals exposed via inhalation or
 
the dermal route. The only information located was a very limited
 
20-day oral study in rats that resulted in osteogenic sarcomas. The
 
data were not sufficient to calculate an MEL by any route. The
 
available toxicokinetic data show that radium can be absorbed and
 
retained after inhalation or oral exposure, although quantitative data
 
are lacking. It would be useful to have information on the effects of
 
intermediate-duration exposure to radium via inhalation, oral, and
 
dermal routes in order to help assess the potential health effects of
 
exposure to radium in the vicinity of hazardous waste sites and other
 
settings, and to evaluate the possibility of long-range effects such as
 
cancer that may emerge years later.
 
Chronic-Duration Exposure and Cancer. A case report is available
 
on human chronic-duration exposure to radium via inhalation and
 
indicates that acute leukopenia, bronchopneumonia, and death occurred in
 
a chemist after 14 years of exposure. A case report is also available
 
on a man who regularly consumed bottles of a "rejuvenating" tonic
 
containing radium for about 5 years, resulting in effects described as
 
necrosis of the jaw, abscess of the brain, secondary anemia,
 
bronchopneumonia, and death. (Each of these causes of death can also be
 
attributed to other etiologies.) Numerous studies have followed the
 
dial painters who ingested radium, and effects reported in these studies
 
include anemia, bone sarcomas, head carcinomas, and death. Although
 
dermal exposure to radium also occurred in these cases, skin effects
 
have not been reported. No data are available on chronic-duration
 
exposure to radium by animals via any route of exposure. The available
 
data were not considered to be adequate to calculate an MEL for any
 
route of exposure. Animal studies on the noncarcinogenic effects of
 
chronic-duration exposure to radium via inhalation, oral, and dermal
 
exposure would be useful in assessing the potential health risks of
 
humans chronically exposed to low levels of radium in the vicinity of
 
hazardous waste sites and other settings.
 
Bone cancer has occurred in humans after chronic-duration oral
 
exposure to radium and in rats that were orally exposed in an
 
intermediate duration study (20 days). It would be useful to have
 
carcinogenicity information from animal studies conducted via
 
32
 
2. HEALTH EFFECTS
 
inhalation, oral, and dermal exposure since humans in the vicinity of
 
hazardous waste sites and other settings would be exposed to radium via
 
all routes of exposure.
 
Genotoxicity. Neither in vitro nor in vivo genotoxicity studies
 
have been located for radium. A battery of in vitro genotoxicity tests
 
may provide useful information on the mechanism of carcinogenicity for
 
radium.
 
Reproductive Toxicity. No studies were located on reproductive
 
effects of radium in humans or animals via inhalation, oral, or dermal
 
exposure. Animal studies using the oral route would be especially
 
useful in evaluating the potential for these effects in human
 
populations exposed to high levels of radium in drinking water (eg.,
 
more than 5 pCi). Studies using dermal and inhalation exposure would
 
also be useful, since these are also probable routes of human exposure
 
to radium in the vicinity of hazardous waste sites and other settings.
 
Developmental Effects. No information has been located on
 
developmental effects in humans or animals resulting from inhalation,
 
oral, or dermal exposure to radium. It was observed that radium-224
 
injected into young children markedly reduced their adult height due to
 
radiation damage to the growth plate in the long bones. Animal studies
 
via inhalation, oral, and dermal exposure would be useful in determining
 
if radium, like calcium, can cross the placenta and enter fetal
 
circulation, and can have adverse effects upon fetal development.
 
Immunotoxicity. Studies that assess the potential effects of
 
radium on the immune system of orally or dermally exposed humans have
 
not been located. The case report of a chemist exposed to radium
 
primarily via inhalation for 14 years reported leukopenia and the almost
 
total absence of granular leukocytes, leukoblastic groups, and lymphoid
 
tissue in the bone marrow. No studies on animals exposed via
 
inhalation, oral, or dermal routes have been located. A study reporting
 
a reduction in peripheral white blood cells in intraperitoneally
 
injected rats has been located. The reported observations suggest that
 
immunological effects may be a concern for humans exposed to radium. A
 
battery of immune function tests conducted in animals via inhalation and
 
the oral and dermal routes would provide useful information relative to
 
this concern.
 
Neurotoxicity. No reports of neurotoxicity resulting from
 
inhalation, oral, or dermal exposure were located in the available human
 
and animal studies. No further information appears to be needed at this
 
time.
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Epidemiological and Human Dosimetry Studies. Two large studies in
 
Germany that follow radium-224 injected patients are being conducted by
 
Spiess and by Wick and Gossner, and the radium study being conducted at
 
Argonne National Laboratory has developed a large data base with
 
information on the radium dial painters, patients who were medically
 
treated with radium, and other persons exposed to radium. These studies
 
will be of value in determining any effects that may be experienced by
 
these aging populations. Additional data are not needed at this time.
 
Biomarkers of Exposure and Effect. Currently, human exposure to
 
radium can be assessed by the presence of radioactivity in the body as
 
measured by a whole body counter and in biological fluids such as blood
 
or urine by gamma spectroscopy.
 
Effects specifically related to radium exposure have not been
 
identified. Studies to identify potential biomarkers of radium's subtle
 
effects would be useful as indicators that immediate mitigation of
 
exposure to radium is warranted or that serious effects such as bone
 
cancer may follow.
 
Absorption, Distribution, Metabolism, and Excretion. Quantitative
 
data on the absorption of radium after intake via any exposure route are
 
very limited. No data were located on the absorption of radium after
 
dermal exposure. Information on laboratory workers exposed to radium
 
during an industrial accident indicates that absorption can occur via
 
the inhalation route. A study in elderly human subjects indicated that
 
at least 20% of the ingested radium-224 in mock radium dial paint was
 
absorbed and retained. No studies were located on the absorption of
 
radium by animals after inhalation or dermal exposure. A study of
 
orally exposed rats indicated that retention of radium at 400 to
 
500 days was 1% to 7% of the administered dose. Further studies to
 
investigate the absorption and retention of radium after inhalation,
 
oral, and dermal exposure would be helpful in elucidating the relative
 
risks associated with exposure by each route.
 
No studies have been located regarding the distribution of radium
 
in humans after oral or dermal exposure. Due to the findings of
 
osteosarcomas in the radium dial painters and in a study in rats and the
 
presence of radium in the exhumed skeletal remains of the dial workers,
 
it is assumed to deposit in the bone after oral exposure. Data from a
 
study of laboratory workers exposed via inhalation during an accident
 
and a case report of a chemist exposed for 14 years also indicate that
 
most radium was deposited in the skeleton. In the case of the chemist,
 
no measurable levels of activity were found in the liver,
 
gastrointestinal tract, heart, or kidneys. Information on radium
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distribution following inhalation, oral and dermal exposure would be
 
useful in helping to determine the potential target organs in persons
 
exposed via each route.
 
Radium salts, such as radium sulfate, can be dissociated to Ra2+
 
and the corresponding anion. However, radium is an element and cannot
 
be metabolized. It is changed over time by the decay of its isotopic
 
forms, each at its own rate. Therefore, no information is needed in
 
this area.
 
Excretion data in orally and parenterally exposed humans indicate
 
that feces is the major route of radium excretion and that biliary
 
excretion is probably also involved. Some urinary elimination also
 
takes place in persons exposed via inhalation, oral, and dermal routes.
 
Continued excretion for months after exposure has been attributed to the
 
release of radium from the lungs in persons exposed via inhalation and
 
from the turnover of bone matrix in persons exposed orally or via
 
parenteral administration. It would be useful to have quantitative
 
information on the excretion patterns of radium administered to animals
 
via inhalation, oral, and dermal administration and to more clearly
 
elucidate the role of biliary excretion in the elimination process.
 
Comparative Toxicokinetics. There are currently not enough data to
 
evaluate any potential species-related differences in response to radium
 
exposure by any route. It would be useful to have information on which
 
animal models most closely approximate humans in this regard in order to
 
help interpret the relevance to humans of any toxicity findings in
 
animal studies. Studies on the toxicokinetics of radium following
 
inhalation, oral, and dermal exposure are needed to compare the
 
different routes of exposure.
 
2.8.3 On-going Studies
 
In Germany, Spiess is following about 900 patients who were
 
injected with radium-224 immediately after World War II. Wick and
 
Gossner are following a larger group of about 1,500 patients injected
 
more recently with lower doses of radium-224. These studies are
 
currently active, and summaries of their data are published
 
periodically.
 
The Center for Human Radiobiology at the Argonne National
 
Laboratory is the repository for all data accumulated in the United
 
States on radium-exposed persons. This study has recently been severely
 
reduced in magnitude, but the records on 5784 cases remain available at
 
the laboratory (Rundo et al. 1986).
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Two large studies of radium and other bone-seeking radionuclides in
 
dogs were conducted at the University of Utah (Wrenn et al. 1986) and at
 
the University of California at Davis (Raabe et al. 1981, 1983).
 
Results of both projects are still being analyzed.
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3. CHEMICAL AND PHYSICAL INFORMATION
 
3.1 CHEMICAL IDENTITY
 
The chemical formula and available identification numbers for
 
radium are listed in Table 3-1.
 
3.2 PHYSICAL AND CHEMICAL PROPERTIES
 
Table 3-2 lists important physical properties of radium and
 
selected radium compounds. Radioactive properties of the four
 
naturally-occurring radium isotopes are listed in Table 3-3. In
 
addition to the naturally occurring isotopes, there are 12 other known
 
isotopes of radium. The principal decay schemes of the uranium and
 
thorium decay series that produce the naturally-occurring radium
 
isotopes are presented in Figure 3-l.
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4. PRODUCTION, IMPORT, USE, AND DISPOSAL
 
4.1 PRODUCTION
 
Between 1913 and 1920, about 70 g of radium were produced by
 
Pittsburgh refineries (Blaufox 1988). No current information on
 
production of radium has been located.
 
4.2 IMPORT
 
No current information has been located on the importation of
 
radium. In the late 1970's, Zaire and Canada were the world's principal
 
producers of radium (HSDB 1988). No quantitative data regarding U.S.
 
imports of radium from those countries have been located.
 
4.3 USE
 
Radium has been used as a radiation source for treating neoplastic
 
diseases, as a radon source, in radiography of metals, and as a neutron
 
source for research (Weast 1985; Windholz 1983).
 
Until the 196Os, radium was a component of the luminous paints used
 
for watch and clock dials, instrument panels in airplanes, military
 
instruments, and compasses (Blaufox 1988).
 
During the early years of this century, radium was used in potions
 
with supposed curative properties. This practice was discontinued by
 
the early 1930's (Blaufox 1988; Macklis 1990).
 
4.4 DISPOSAL
 
Because radium is a radioactive substance, disposal of wastes
 
containing radium is controlled by a number of federal and state
 
regulations (see Chapter 7). Both the EPA and the Nuclear Regulatory
 
Commission have promulgated regulations for land disposal of these
 
wastes detailing containment requirements and permissible exposure
 
levels based on radioactivity.
 
On a global level, the amount of radium released to the environment
 
OK disposed of through industrial use is considered to be insignificant
 
compared to the natural occurrence of radium in the environment. Radium
 
is present in the wastes of uranium mining and refining processes, and
 
disposal of these wastes is regulated.
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5.1 OVERVIEW
 
Radium is a naturally-occurring metal that is almost ubiquitous in
 
soils, water, geologic materials, plants, and foods at low
 
concentrations. The utilization of radium, uranium, and fossil fuels
 
has resulted in the redistribution of radium in the environment by way
 
of air, water, and land releases. The concentration of radium in
 
natural water is usually controlled by adsorption-desorption reactions
 
with minerals and rocks and by the solubility of radium-containing
 
minerals. In addition, radium is constantly being produced by the
 
radioactive decay of its precursors, uranium, and thorium. Radium does
 
not degrade other than by radioactive decay at rates which are specific
 
to each of four naturally-occurring isotopes. The concentrations of
 
radium-226 and radium-228 in drinking water are generally low, but there
 
are specific geographic regions where high concentrations of radium
 
occur due to geologic sources. Radium may be bioconcentrated and
 
bioaccumulated by plants and animals, and it is transferred through food
 
chains from lower trophic levels to humans.
 
The frequency of NPL hazardous waste sites in the United States at
 
which radium has been found at higher than background levels can be seen
 
in Figure 5-l.
 
5.2 RELEASES TO THE ENVIRONMENT
 
5.2.1 Air
 
The combustion of coal may be the most important mechanism for
 
releasing radium into the atmosphere. The mean concentration of
 
radium-226 in coal is on the order of 1 pCi/g (0.04 Bq/g). When
 
combusted, radium may volatilize, then condense onto coal fly ash
 
particles, which in turn may be released from power plants as fugitive
 
emissions. The concentrations of radium-226 in fly ash have ranged from
 
1 to 10 pCi/g (0.04 to 0.4 Bq/g) (Coles et al. 1978; Eisenbud and Petrow
 
1964; Morris and Bobrowski 1979).
 
The radium-228 content of fly ash has varied from 1.8 to 3.1 pCi/g
 
(0.07 to 0.12 Bq/g) (Eisenbud and Petrow 1964). If it is assumed that
 
the total radium content of fly ash is 5 pCi/g (0.19 Bq/g), and that 1%
 
of the ash generated at all coal-fired power plants in the United States
 
escapes into the atmosphere, then an order-of-magnitude estimate of the
 
amount of radium released each year would be 2.2 Ci (81,000,OOO kBq)
 
(Roy et al. 1981). Eisenbud and Petrow (1964) estimated that a single
 
lOOO-megawatt coal-fired power plant will discharge about 28 mCi
 
(1,037,OOO kBq) of total radium per year. Radium-226 has been detected
 
in soils in industrial regions at levels up to 8.1 pCi/g (0.30 Bq/g)
 
(Jaworowski and Gryzbowska 1977).
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Global releases of radium-226 by the combustion of coal have been
 
estimated as 150 Ci (5,550,000,000 kBq) per year (Jaworowski et al.
 
1971). It has also been observed that radium-226 concentrations in
 
glacial ice samples collected in Europe have increased by a factor of
 
100 during the last 80 years. The source of these elevated levels of
 
radium may have been emissions from fossil fuels (Jaworowski et al.
 
1971).
 
Another potential source of atmospheric radium is particulate
 
matter created by uranium mining and milling operations. However, no
 
information was located on estimated releases or atmospheric
 
concentrations.
 
5.2.2 Water
 
The most significant water-related releases of radium may be from 
the leaching of uranium mine tailings and from the release of ore 
-processing effluents generated by leaching, decantation, and filtration 
processes. Approximately 97 million tons of mine tailings that contain 
an estimated 60,000 Ci (2.2 x l09 kBq) of radium-226 have been 
stockpiled at the surface in the western United States (Kaufmann et al. 
1976). It has been estimated that 10 million tons of uranium mine 
tailings are generated each year in Canada (Kalin 1988). Laboratory 
extraction studies (Havlik et al. 1968a, 1968b) have demonstrated that 
radium-226 may leach from solid wastes, particularly by acidic 
wastewaters. Surface runoff and leachate from uranium mine tailings 
have contained radium-226 ranging from 38 to 116 pCi/L (1.4 to 4.3 Bq/L) 
(Kalin 1988; Swanson 1985). Untreated uranium milling effluent has 
contained radium-226 at up to 2.2 µCi/L (81 kBq/L) (Sebesta et al. 
1981). In the past, leachate from mine tailings containing radium-226 
concentrations of 53 to 292 pCi/L (2 to 11 Bq/L) has been deep-well 
injected (Kaufmann et al. 1976). Approximately 2,000 to 3,000 Ci 
(74,000,000,000 to 111,000,000,000 kBq) of total radioactivity were 
released to the subsurface by two uranium mills in New Mexico. No 
information was located on the total amount of radium released to the 
environment by water-related discharges. As discussed in Section 5.4.2, 
however, concentrations of radium-226 and radium-228 found in surface 
and ground water sources have generally been low. 
5.2.3 Soils
 
Land releases of radium are related to atmospheric fallout of coal
 
fly ash (see Section 5.2.1). For example, elevated radium-226
 
concentrations in snow have been detected near a coal-fired power plant
 
in Poland (Jaworowski et al. 1971). Other land releases may include the
 
disposal of coal fly ash, lime slurry derived from water softening
 
processes, and uranium mine tailings and associated wind-blown dusts.
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However, no information was located on the total amount of land-released
 
radium.
 
5.3 ENVIRONMENTAL FATE
 
Radium may be transported in the atmosphere in association with
 
particulate matter. It exists primarily as a divalent ion in water, and
 
its concentration is usually controlled by adsorption-desorption
 
mechanisms at solid-liquid interfaces and by the solubility of radiumcontaining
 
minerals. Radium does not degrade in water other than by
 
radioactive decay at rates that are specific to each isotope. Radium
 
may be readily adsorbed by earth materials; consequently, it is usually
 
not a mobile constituent in the environment. It may be bioconcentrated
 
and bioaccumulated by plants and animals, and it is transferred in food
 
chains from lower trophic levels to humans.
 
5.3.1 Transport and Partitioning
 
5.3.1.1 Air
 
Radium may be transported in the atmosphere by the movement of
 
particulate matter derived from uranium and coal utilization (see
 
Section 5.2.1). These fugitive emissions would be subject to
 
atmospheric dispersion, gravitational settling and wash-out by rain.
 
No data were located on the residence time of radium in the
 
atmosphere or its deposition rate. However, data for other elements
 
adsorbed to particulate matter indicate that the residence time for fine
 
particles is about 1 to 10 days (EPA 1982b; Keitz 1980). Radium may,
 
therefore, be subject to long-range transport in the atmosphere.
 
5.3.1.2 Water
 
Radium in water exists primarily as a divalent ion (Ra2+) and has 
chemical properties that are similar to barium, calcium, and strontium. 
The solubility of radium salts in water generally increases with 
increased pH levels. The solubilities of radium sulfate and carbonate 
are low; the solubility constants for crystalline RaSO, and RaCO, have 
been estimated as 5.495 x 10-11 mole/L and 5.01 x 10-9 mole/L,respectively 
(Langmuir and Riese 1985). Radium nitrate, chloride, and iodate are very 
soluble in water (Ames and Rai 1978). However, the concentration of radium in 
water is usually controlled by adsorptiondesorption reactions at solid-liquid 
interfaces which are in turn influenced by pH (see Section 5.3.1.3) or by the 
dissolution and coprecipitation of minerals that contain radium (EPA 1985a; 
Langmuir and Riese 1985). The tendency for radium to coprecipitate with barite, 
and sparingly soluble barium sulfate, as (BaRa)SO4 is well known. Moreover,
 
water treatment by adsorption and water-softening techniques are thought
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to be effective in reducing radium in untreated drinking water (Watson
 
et al. 1984). Therefore, it is likely that radium in water does not
 
migrate significantly from the area where it is released or generated
 
(EPA 1985a). Limited field data also support the generalization that
 
radium is not mobile in groundwater (Kaufmann et al. 1976; Swanson
 
1985).
 
5.3.1.3 Aquifers, Sediments, and Soils
 
Radium in water may be readily adsorbed by sediments, soils, and
 
aquifer components. It has been experimentally demonstrated that radium
 
can be adsorbed by soils and sediments (Benes and Strejc 1986; Landa and
 
Reid 1982), ferric hydroxide and quartz (Benes et al. 1984; Valentine
 
et al. 1987), kaolinite and montmorillonite (Benes et al. 1985), and
 
muscovite and albite (Benes et al. 1986).
 
Partition coefficients such as adsorption constants (Kd) describe 
the tendency of chemicals to partition to solid phases from water. 
Adsorption constants for inorganic ions such as Ra2+ cannot be predicted 
a priori because they depend on the type of adsorbent, the pH of the 
water, and the presence of other ions in solution. Kd values for sand 
have varied from 18 to 1,742 mL/g in the pH range of 7.4 to 8.3 (Benes 
et al. 1984; Valentine et al. 1987). Kd values for clay minerals and 
other common rock-forming minerals have ranged from 2,937 to 90,378 mL/g 
in alkaline solutions (Benes et al. 1985, 1986). Similarly, Kds for 
soils in alkaline solutions have ranged from 214 to 467 mL/g (Ames and 
Rai 1978). Adsorption constants based on field studies with lake 
sediments have varied from 205 to 15,833 mL/g (Swanson 1985). The 
magnitude of these adsorption constants indicate that partitioning to 
solid surfaces is a major removal mechanism of radium from water. 
Swanson (1985) concluded that about 90% of the radium-226 released by 
uranium-mine effluent to two small lakes was adsorbed by the lake 
sediments and algae-detrital material. 
The removal of Ra2+ by adsorption has been attributed to ion 
exchange reactions, electrostatic interactions with potential determining 
ions at mineral surfaces, and surface-precipitation with 
BaSO4. The adsorptive behavior of Ra2+ is similar to that of other 
divalent cationic metals in that it decreases with an increase in pH 
and is subject to competitive interactions with other ions in solution 
for adsorption sites. In the latter case, Ra2+ is more mobile in 
groundwater that has a high total dissolved solids (TDS) content. It 
also appears that the adsorption of Ra2+ by soils and rocks may not be a 
completely reversible reaction (Benes et al. 1984, 1985; Landa and Reid 
1982). Hence, once adsorbed, radium may be partially resistant to 
removal, which would further reduce the potential for environmental 
release and human exposure. 
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5.3.1.4 Plants and Animals
 
Transfer from soil to plants. Radium in the soil may be readily 
absorbed by plants, depending on the specific plant type and soil (Rayno 
1983). Elevated concentrations of radium-226 above background levels 
have been detected in areas where radium and/or uranium was mined or 
processed (Kalin 1988; Rayno 1983; Tracy et al. 1983; Watson et al. 
1984). The partitioning of radium-226 to plants from soils has been 
estimated by measuring the ratio of radium activity (or concentration) 
in the plant mass to that in the host soil. Soil-plant transfer 
coefficients or concentration factors have ranged from 1.1 x 10-3 to 6.5 
(Rayno 1983; Tracy et al. 1983). Watson et al. (1984) concluded that a 
reasonable radium-226-concentration factor for fruits is 3 x 10-3 and 
that 0.1 describes the partitioning of radium-226 to forage and hay. An 
unweighted mean concentration factor for grain was 0.63. No information 
was located on soil-to-plant transfers for radium-228; however, its 
properties in this regard may be similar to those of radium-226. 
Transfer from plants to cattle. There is a potential for human 
exposure to radium by the consumption of beef and milk derived from 
cattle who graze on forage grown in soils containing radium. The mean 
ratio of radium-226 in milk to that in the animal's diet has been 
estimated to be 3.8 x 10-3 (Watson et al. 1984). A similar ratio or 
transfer coefficient for flesh was 6.8 x 10-3 . 
Transfer from water to aquatic organisms. Aquatic organisms such
 
as fish, snails, clams, and algae can bioaccumulate radium from water.
 
Bioconcentration factors (BCFs) for fish living in streams or lakes
 
receiving uranium-processing waste effluent have ranged from 1 to 60 for
 
flesh portions, and from 40 to 1,800 in bone samples (Markose et al.
 
1982; Swanson 1985). It has been proposed that bottom-feeding organisms
 
ingest suspended solids containing adsorbed radium, then are in turn
 
consumed by larger predatory fish.
 
5.3.2 Transformation and Degradation
 
5.3.2.1 Air
 
Pure metallic radium oxidizes when exposed to air, but radium
 
compounds suspended in air are not subject to transformation or
 
degradation mechanisms.
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5.3.2.2 Water
 
Radium in water exists as a stable divalent ion; it probably does
 
not hydrolyze nor is it significantly influenced by oxidation-reduction
 
reactions (Ames and Rai 1978). The solubility of radium salts is
 
increased with increasing pH levels.
 
5.3.2.3 Soil
 
Radium in soils and sediment does not biodegrade nor participate in
 
any chemical reactions that transform it into other forms. The only
 
degradation mechanism operative in air, water, and soil is radioactive
 
decay. Radium has 16 known isotopes (see Chapter 3), but only 4 occur
 
naturally (Radium-223, -224, -226, and -228). The half-life of
 
radium-226 is 1,620 years. The half-lives of radium-228, radium-223,
 
and radium-224 are 5.77 years, 11.4 days, and 3.64 days, respectively.
 
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
 
Radium is a naturally-occurring metal and is almost ubiquitous at
 
low concentrations in air, water, soil, rocks, and food. The median
 
concentrations of radium-226 and radium-228 in drinking water are
 
generally low, but there are geographic areas where higher
 
concentrations of radium are known to occur. The utilization of coal
 
and uranium has resulted in re-distributing radium in the environment,
 
but the overall effects appear to be small. Estimated levels of average
 
human exposure to radium of non-occupational populations are presented in
 
Table 5-l.
 
5.4.1 Air
 
Dust samples collected from the atmosphere of New York City were 
found to contain radium-226 at 8 x 10-5 pCi/m3 (3.0 x 10-6 Bq/m3) and 
radium-228 at 1.5 x 10-4 pCi/m3 (5.6 x 10-6 Bq/m3) (Eisenbud and Petrow 
1964). No other published data on ambient concentrations of radium in 
the atmosphere were located. 
5.4.2 Water
 
Radium is a naturally-occurring and fairly ubiquitous metal at low
 
concentrations in water and rock-forming minerals. It has been
 
estimated that the total mass of radium-226 in the earth's oceans is
 
about 150 tons (Fremlin and Abu Jarad 1980). The occurrence of radium
 
in ground, surface, and finished (treated) drinking water has been
 
assessed (Aieta et al. 1987; Cech et al. 1988; EPA 1985a; Hess et al.
 
1985; Longtin 1988; Lucas 1985; Michel and Cothern 1986; Watson et al.
 
1984). In general, shallow wells tend to have lower radium-226
 
concentrations than deeper wells, and the total content in municipal
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(treated) water supplies is lower than that in raw well water (Watson
 
et al. 1984). The radium content of surface water is usually very low.
 
Radium-226 generally ranges from 0.1 to 0.5 pCi/L (0.004 to 0.019 Bq/L)
 
(Hess et al. 1985). Based on 990 random samples of drinking water from
 
ground water sources, the average population-weighted concentrations of
 
radium-226 and radium-228 in the United States (excluding Hawaii) were
 
about 0.91 pCi/L (0.034 Bq/L) and 1.41 pCi/L (0.052 Bq/L), respectively
 
(Longtin 1988). Approximately 90% of these samples contained radium-226
 
at less than 1 pCi/L (0.04 Bq/L); similarly, about 90% contained
 
radium-228 at less than 1 pCi/L (0.04 Bq/L). (These were not
 
necessarily the same water sources.) However, there were approximately
 
200 public water supplies with radium-226 activities after treatment
 
that were in excess of the regulatory maximum contaminant level (MCL) of
 
5 pCi (0.19 Bq) total radium/L (Hess et al. 1985). The mean radium-226
 
activity of the supplies in excess of the MCL was about 10 pCi/L
 
(0.37 Bq/L).
 
A survey on the occurrence of radium-228 in municipal water
 
supplies in Illinois, Iowa, Missouri, and Wisconsin indicated that the
 
activity of this isotope may range from 0.3 to 32.0 pCi/L (11.1 to
 
1,180 mBq/L) (Lucas 2985), while Michel and Cothern (1986) reported that
 
typical concentrations are less than 1 pCi/L (37 mBq/L).
 
There are few data on the occurrence of radium-224 in water. It
 
has been speculated that the activity of this isotope could approach 30
 
to 40 pCi/L (1,110 to 1,480 mBq/L) (EPA 1985a).
 
Data on the presence of radon in groundwater can be used as a guide
 
to the presumably corresponding presence of radium in the same source.
 
Based on descriptions of aquifer composition or lithology and data from
 
state water-resource agencies, counties with potentially high levels of
 
radon in groundwater have been identified by Michel (1987). These
 
estimates indicate that the U.S. counties with the highest levels of
 
radium would be found in many areas of the Western third of the country,
 
including large areas of California, Nevada, Idaho, and Montana.
 
Wisconsin and Minnesota would also have high levels. In the East, the
 
Appalachian Mountain region including almost all of Maine and New
 
Hampshire would have high levels, as well as a large section of central
 
Florida. It is important to note that quantitative estimates are not
 
available, and the potentially "high" values for radon and radium imply
 
only a comparison to other areas, not necessarily a risk to human health
 
or the environment.
 
5.4.3 Soil
 
The mean concentration of radium-226 in 356 surface soil samples
 
collected from 0 to 6 cm in 33 states was 1.1 pCi/g (0.041 Bq/g) (Myrick
 
et al. 1981). This mean concentration is very similar to those reported
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for typical igneous rocks (1.3 pCi/g or 0.048 Bq/g), sandstone
 
(0.71 pCi/g or 0.026 Bq/g), shale (1.1 pCi/g or 0.041 Bq/g), and
 
limestone (0.42 pCi/g or 0.016 Bq/g) (Eisenbud 1973). The concentration
 
of radium-226 in soils in Northern Italy was reported to average
 
0.72 pCi/g [range: 0.08 to 3.8 pCi/g (0.003 to 0.14 Bq/g)] (DeBortoli
 
and Gaglione 1972), excluding regions with extremely high levels of
 
natural radioactivity (no data presented).
 
The concentrations of radium-226 in soils that were contaminated by
 
mining or milling activities have ranged from less than 1 to 3,700 pCi/g
 
(0.037 to 137 Bq/g) (Kalin 1988; Landa 1984; Tracy et al. 1983). No
 
information was located on the occurrence of the other radium isotopes
 
in soil or rocks.
 
The presence of uranium in soil can be used as an indication of
 
occurrence of radium and radon in the same location. Based on
 
geological reports and data synthesized from the National Uranium
 
Resource Evaluation (NURE) program, areas with potentially high radon
 
levels in soil gas have been identified by Michel (1987). These areas
 
would have correspondingly high soil radium levels, although
 
quantitative estimates are not available. These uranium "hot spots"
 
occur with more frequency in the Western third of the United States, and
 
include large areas of California and Idaho. High concentrations have
 
been found in Wisconsin and Minnesota and a very dense area has been
 
identified in western Missouri/eastern Kansas. In the East, high levels
 
appear generally along the Appalachian mountains and near industrialized
 
sites. High levels have also been found in the northern to central
 
sections of Florida.
 
5.4.4 Other Media
 
Radium-226 may occur in many different foods, and reported
 
activities have varied considerably. The mean radium-226 contents of
 
diets in 11 cities in the United States were estimated to be 0.52 to
 
0.73 pCi/kg of food consumed (0.019 to 0.027 Bq/kg) (Eisenbud 1973).
 
Estimates of the mean concentrations of radium-226 in milk and beef are
 
0.23 pCi/L (0.009 Bq/L) and 0.22 pCi/kg (0.008 Bq/kg) (fresh weight),
 
respectively, in the United States (Watson et al. 1984). No information
 
was located on the occurrence of radium-228 in food.
 
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
 
Major sources of exposure to radium by the general population are
 
the consumption of drinking water and food (Table 5-l). Of the many
 
radionuclides found in nature, radium is considered to be one of the
 
most important because of its wide occurrence in groundwater, and
 
because it, like calcium, is retained in bone tissues (Aieta et al.
 
1987). Bone cancer is the greatest health risk from exposure to radium.
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Based on assumptions about the concentration of radium in drinking water
 
provided by utilities, the size of the population consuming this water,
 
and the associated risk of cancer, Hess et al. (1985) estimated that the
 
average concentration of radium in drinking water may cause cancer in
 
941 persons per year in the United States. The risk of exposure to
 
radium in food is uncertain because of the variability in diets and in
 
the radium-226 content of foods. It has been estimated that the yearly
 
intake of radium-226 for food in New York City is on the order of 640
 
pCi (24 Bq) (Eisenbud 1973).
 
Levels of occupational exposure to radium are difficult to assess.
 
Workers who are occupationally exposed to radium through the mining and
 
processing of uranium are also probably exposed simultaneously to
 
uranium itself, thorium, and radon by inhalation and probably dermal
 
exposure. Nielson and Rogers (1981) suggested that inhalation exposures
 
during uranium mining and milling operations involving crushing,
 
grading, or blasting are the most significant routes of exposure. There
 
is also some concern about ingesting dust at processing plants (Dixon
 
1985). It has also been suggested that inhalation of
 
fugitive emissions from mine tailings could be locally significant
 
(Ruttenber et al. 1984), but radium-specific data were not located.
 
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
 
The populations at greatest risk of exposure from the consumption
 
of drinking water with a high radium content are located in the Piedmont
 
and Coastal Plain province in New Jersey, North Carolina, South
 
Carolina, and Georgia and parts of Minnesota, Iowa, Illinois, Missouri,
 
and Wisconsin (Hess et al. 1985; Longtin 1988). It has been estimated
 
that about 600,000 people consume water with radium-226 concentrations
 
in excess of the MCL (5 pCi/L or 0.19 Bq/L) in Illinois, Iowa, Missouri,
 
and Wisconsin. Isolated occurrences of high radium-226 have also been
 
detected in Arizona, New Mexico, Texas, Mississippi, Florida, and
 
Connecticut. There is also a high probability of exposure to high
 
radium-228 concentrations in many of the states listed above in addition
 
to parts of California, Colorado, Idaho, Montana, New Mexico, and
 
Wyoming (Michel and Cothern 1986).
 
It has been suggested that uranium miners and millers who are in
 
chronic contact with dust are at risk. However, such workers are
 
simultaneously exposed to several radionuclides and no generalization
 
specific to radium can be made.
 
5.7 ADEQUACY OF THE DATABASE
 
Section 104(i)(5) of CERCIA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of
 
the Public Health Service) to assess whether adequate information on the
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health effects of radium is available. Where adequate information is
 
not available, ATSDR, in conjunction with the National Toxicology
 
Program (NTP), is required to assure the initiation of a program of
 
research designed to determine the health effects (and techniques for
 
developing methods to determine such health effects) of radium.
 
The following categories of data needs have been identified by a
 
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
 
substance-specific informational needs that, if known, would reduce or
 
eliminate the uncertainties of human health assessment. Each data need
 
discussion highlights the availability, or absence, of the relevant
 
exposure information. A statement that reflects the importance of
 
identified data needs is also included. In the future, these data needs
 
will be evaluated and prioritized, and a substance-specific research
 
agenda will be proposed.
 
5.7.1 Identification of Data Needs
 
Physical and Chemical Properties. Although some of the physical
 
and chemical properties of radium and radium compounds have not been
 
determined, many of those that are needed to evaluate its behavior in
 
the environment are known. The adsorption-desorption behavior of radium
 
with geologic materials depends on the specific system under study and
 
should be determined on a case-by-case basis. Also, thermodynamic and
 
kinetic data for solid solution formation are scarce. Research in this
 
area would facilitate modeling the fate of radium in water.
 
Production, Import, Use, and Disposal. Radium is apparently used
 
only in small quantities (e.g., in laboratories) in the United States.
 
The quantities discharged to the environment from this source are
 
probably insignificant compared to naturally-occurring radium. However,
 
data on actual amounts of radium currently in use and amounts disposed
 
of as waste would be useful in estimating human exposure potential.
 
Environmental Fate. Studies of releases of radium that result from
 
uranium mining and processing would be helpful to fully assess the total
 
amount and environmental fate of radium released to the environment.
 
Field data on the mobility of radium in groundwater would also be
 
helpful in attempts to predict its potential for occurrence in sources
 
of drinking water at remote sites.
 
Bioavailability from Environmental Media. Data on the absorption
 
of radium from environmental media via inhalation, oral, and dermal
 
exposure would be useful in determining potential risks for organisms
 
(humans, animals and plants) that have been exposed to radium in air,
 
soil, or natural waters.
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Food Chain Bioaccumulation. The existing information indicates
 
that radium may be transferred through the food chain from lower trophic
 
levels to humans. Additional monitoring studies in areas where radium
 
occurs naturally at high concentrations in soil would be helpful to
 
determine if this pathway is a significant route of exposure. The
 
transfer of radium-228 from soils through the food chain has not been
 
assessed.
 
Exposure Levels in Environmental Media. The concentration of
 
radium-226 in drinking water has been the subject of numerous studies,
 
and average values are reasonably well known. It appears that emphasis
 
could be given to monitoring radium-226 concentrations in regions where
 
high concentrations are expected to occur ("hot spots"), such as regions
 
with high levels of natural radioactivity, in the vicinity of uranium
 
mining and milling operations, and at NPL and other hazardous waste
 
sites. Information on the occurrence of radium in the atmosphere would
 
also be useful in helping to predict exposure via inhalation.
 
The occurrence of radium-228 has not been as well established, and
 
additional data would be helpful, particularly in geologic regions where
 
high concentrations are likely. There is virtually no information on
 
the occurrence and levels of radium-223 and radium-224 in drinking
 
water. The occurrence and levels of any of the isotopes of radium in
 
food are highly variable, and additional data would facilitate exposure
 
estimates.
 
Exposure Levels in Humans. There is no information available on
 
the general background levels of radium in human tissue. Information on
 
these levels, especially in the skeleton, would be especially useful as
 
a means to monitor continuing exposure to radium.
 
Exposure Registries. A national exposure registry for persons
 
exposed to radium was not located but would be useful in relating
 
factors such as age, sex, season, geography, regulations, environment
 
and other factors to measured exposure concentrations and health
 
outcomes.
 
5.7.2 On-going Studies
 
The EPA is presently conducting a survey called the National
 
Inorganics and Radionuclides Survey (NIRS). This study has been ongoing
 
since 1981, and preliminary reports have been published. These
 
data are still being analyzed for the establishment of revised interim
 
drinking water regulations.
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The purpose of this chapter is to describe the analytical methods
 
that are available for detecting and/or measuring and monitoring radium
 
in environmental media and in biological samples. The intent is not to
 
provide an exhaustive list of analytical methods that could be used to
 
detect and quantify radium. Rather, the intention is to identify well
 
established methods that are used as the standard methods of analysis.
 
Many of the analytical methods used to detect radium in environmental
 
samples are the methods approved by federal agencies such as EPA and the
 
National Institute for Occupational Safety and Health (NIOSH). Other
 
methods presented in this chapter are those that are approved by a trade
 
association such as the Association of Official Analytical Chemists
 
(AOAC) and the American Public Health Association (APHA). Additionally,
 
analytical methods are included that refine previously used methods to
 
obtain lower detection limits and/or to improve accuracy and precision.
 
6.1 BIOLOGICAL MATERIALS
 
The presence of radium in biological materials or environmental
 
samples is generally determined by virtue of its radioactivity. Except
 
in the laboratory where radium compounds have been isolated and
 
determined for a certain purpose, determination of radium compounds in
 
biological and environmental samples is relatively rare. As a Group IIA
 
alkaline earth element, radium is similar in its chemical behavior to
 
other members of that group, especially its nearest neighbor, barium.
 
For example, radium tends to precipitate as the sulfate, which is the
 
basis for its isolation for chemical analysis by coprecipitation with
 
barium sulfate. Furthermore, radium associates with calcium in living
 
systems and accumulates in bone. The determination of radium compounds
 
or specific isotopes is usually accomplished by a separation procedure,
 
followed by quantitative analysis of total radium based on its
 
radioactivity.
 
Radium is determined in both biological and environmental samples
 
by the emission of ionizing radiation from its radioisotopes (alphae­
emitting radium-223, radium-224, and radium-226, as well as
 
beta-emitting radium-228) and from its daughter products. Gamma-ray
 
spectrometry of the gamma rays emitted by decay products of radium can
 
also be used to measure radium. One of the most important examples is
 
the measurement of gamma rays emitted by 214Bi (Davis et al. 1987).
 
Intermediate loss of radon gas in the decay chain can be troublesome in
 
this kind of measurement. One method of radium measurement in bone
 
collects the radioactive radon-222 gas product of the decay of radium­
226, and its radioactivity is measured and extrapolated back to the
 
concentration of radium-226 (Walton et al. 1959).
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A method has been developed to measure the rate of elimination of
 
radon in exhaled breath (Stehney et al. 1955). Based on the assumption
 
that 70% of the radon from fixed body radium is exhaled, this test can
 
be used to calculate approximate levels of the body burden of radium.
 
Some analytical methods for the determination of radium in
 
biological materials are given in Table 6-l. It is important to note
 
that the major contributions of these studies are descriptions of sample
 
preparation techniques rather than advances in alpha or gamma
 
spectrometry.
 
6.2 ENVIRONMENTAL SAMPLES
 
Because small amounts of radium radionuclides in environmental
 
samples may be regarded as hazardous, it is usually necessary to detect
 
very small quantities of radium which may require processing large
 
quantities of sample (Quinby-Hunt et al. 1986). This introduces
 
possibilities for contamination and sample loss. Specifically, in the
 
case of water samples, sorption of the radionuclide to container walls
 
and to suspended matter may be important sources of error.
 
Significant concentrations of contaminant radium may be
 
submicromolar. Therefore, radiochemical separations are commonly
 
employed that make use of a carrier, a nonradioactive element with
 
chemical properties similar to those of radium. For radium, barium is
 
the element of choice, and radium is coprecipitated from solution with
 
barium sulfate, BaSO4. Correction for losses in the precipitation
 
procedure may be made by adding a tracer consisting of an isotope of
 
radium not expected in the sample and noting its recovery at the end of
 
the analytical procedure. The isotope radium-223 can be used for this
 
purpose.
 
Radium is commonly determined in environmental samples by the
 
emission of alpha particles from the radium-226 radioisotope. Beta-

emitting radium-228 can also be measured. Measurement of the
 
radioactive radon-222 gas product of the decay of radium-226 can be used
 
to give the concentration of radium-226. Gamma-ray spectroscopy of
 
daughter radioisotopes such as 214Bi can also be used to determine
 
radium.
 
Because of the low penetrating power of alpha particles, special
 
counters are required to assay alpha activity. These include gas-filled
 
counters (thin window or internal, proportional counters), scintillation
 
counters, and semiconductor detectors. In addition, a very thin sample
 
is required to prevent the sample itself from absorbing alpha particles.
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A promising method has been developed for measuring radium-226
 
concentrations in water samples of one liter size (Whittaker 1986). All
 
nongaseous alpha-emitting radionuclides are coprecipitated with barium
 
sulfate and iron hydroxide, followed by counting alpha emissions from
 
the precipitate. A count at 3 hours followed by one at 7 days is used
 
to measure radium-226.
 
Some analytical methods for the determination of radium in
 
environmental samples are given in Table 6-2.
 
6.3 ADEQUACY OF THE DATABASE
 
Section 104(i)(5) of CERCLA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of
 
the Public Health Service) to assess whether adequate information on the
 
health effects of radium is available. Where adequate information is
 
not available, ATSDR, in conjunction with the National Toxicology
 
Program (NTP), is required to assure the initiation of a program of
 
research designed to determine the health effects (and techniques for
 
developing methods to determine such health effects) of radium.
 
The following categories of data needs have been identified by a
 
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
 
substance-specific informational needs that, if known, would reduce or
 
eliminate the uncertainties of human health assessment. Each data need
 
discussion highlights the availability, or absence, of the relevant
 
exposure information. A statement that reflects the importance of
 
identified data needs is also included. In the future, these data needs
 
will be evaluated and prioritized, and a substance-specific research
 
agenda will be proposed.
 
6.3.1 Identification of Data Needs
 
Methods for Determining Biomarkers of Exposure and Effect. As
 
discussed above, the presence of radium in biological materials is
 
usually determined by virtue of its radioactivity. Methods available
 
for the determination of radioactivity in biological materials include
 
alpha spectroscopy and gamma spectrometry, which is more convenient, but
 
generally less sensitive, than alpha spectroscopy (Joshi 1987). It
 
would be useful to have additional data on the sensitivity and accuracy
 
of the methods that are currently in use.
 
Effects specifically associated with radium exposure have not been
 
identified. The development of methods for detecting biomarkers of
 
radium's effects would be useful.
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Methods for Determining Parent Compounds and Degradation Products
 
in Environmental Media. It would be useful to have data on the
 
sensitivity and accuracy of methods that are currently used to determine
 
radium in environmental media. In addition, continued development of
 
sensitive and accurate methods and instrumentation that would minimize
 
problems with background and contamination would be useful in
 
determining radium levels in environmental media. It would also be
 
useful to develop portable, compact instruments to conduct field
 
analyses with optimum sensitivity and accuracy.
 
6.3.2 On-going Studies
 
Refinements continue to be made in detecting radioactivity from
 
radium isotopes and their daughter products. These developments include
 
better, more sensitive detectors and more efficient data handling
 
systems. Substantial improvements may be anticipated in the area of
 
high resolution gamma spectroscopy. Research is underway to improve
 
sample preparation and separation to give more sensitive analysis and
 
better speciation. Because of the demands of cleanup programs including
 
Superfund II, the Formerly Utilized Sites Remedial Action Program, and
 
the Uranium Mill Tailings Remedial Action Program, research is underway
 
to increase sample output and to decrease time and costs per sample
 
(Donivan et al. 1987).
 
65
 
7. REGULATIONS AND ADVISORIES
 
International and national regulations and guidelines pertinent to
 
human exposure to radium are summarized in Table 7-l. Recommendations
 
for radiation protection for people in the general population as a
 
result of exposure to radiation in the environment are found in the
 
Federal Radiation Guidance (FRC 1960) and ICRP No. 26 (ICRP 1977).
 
National guidelines for occupational radiation protection are found in
 
the "Federal Radiation Protection Guidance for Occupational Exposure"
 
(EPA 1987). This guidance for occupational exposure supercedes
 
recommendations of the Federal Radiation Council for occupational
 
exposure (FRC 1960). The new guidance presents general principles for
 
the radiation protection of workers and specifies the numerical primary
 
guides for limiting occupational exposure. These recommendations are
 
consistent with the ICRP (ICRP 1977).
 
The basic philosophy of radiation protection is the concept of
 
AURA (As Low As Reasonably Achievable). As a rule, all exposure should
 
be kept as low as reasonably achievable, and the regulations and
 
guidelines are meant to give an upper limit to exposure. Based on the
 
primary guides (EPA 1987a), guides for Annual Limits on Intake (ALIs)
 
and Derived Air Concentrations (DACS) have been calculated (EPA 1988).
 
The AL1 is defined as "that activity of a radionuclide which, if inhaled
 
or ingested by Reference Man (ICRP 1975), will result in a dose equal to
 
the most limiting primary guide for committed dose" (EPA 1988; ICRP
 
1979) (see Appendix B). The DAC is defined as "the concentration of
 
radionuclide in air which, if breathed by Reference Man (ICRP 1975) for
 
a work-year, would result in the intake of one AL1 (EPA 1988). The ALIs
 
and DACs refer to occupational situations but may be converted to apply
 
to exposure of persons in the general population by application of
 
conversion factors (Table 7-l).
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Absorbed Dose -- The mean energy imparted to the irradiated medium, per
 
unit mass, by ionizing radiation. Units: gray (GY), rad.
 
Absorbed Fraction -- A term used in internal dosimetry. It is that
 
fraction of the photon energy (emitted within a specified volume of
 
material) which is absorbed by the volume. The absorbed fraction
 
depends on the source distribution, the photon energy, and the size,
 
shape and composition of the volume.
 
Absorption -- The process by which radiation imparts some or all of its
 
energy to any material through which it passes.
 
Self-Absorption -- Absorption of radiation (emitted by radioactive
 
atoms) by the material in which the atoms are located; in
 
particular, the absorption of radiation within a sample being
 
assayed.
 
Absorption Coefficient -- Fractional decrease in the intensity of an
 
unscattered beam of x or gamma radiation per unit thickness (linear
 
absorption coefficient), per unit mass (mass absorption coefficient), or
 
per atom (atomic absorption coefficient) of absorber, due to deposition
 
of energy in the absorber. The total absorption coefficient is the sum
 
of individual energy absorption processes. (See Compton Effect,
 
Photoelectric Effect, and Pair Production.)
 
Linear Absorption Coefficient -- A factor expressing the fraction 
of a beam of x or gamma radiation absorbed in a unit thickness of 
material. In the expression I=Ioe-µx , Io is the initial intensity, 
I the intensity of the beam after passage through a thickness of 
the material x, and µ is the linear absorption coefficient. 
Mass Absorption Coefficient -- The linear absorption coefficient
 
per cm divided by the density of the absorber in grams per cubic
 
centimeter. It is frequently expressed as µ/•, where µ is the
 
linear absorption coefficient and p the absorber density.
 
Absorption Ratio, Differential -- Ratio of concentration of a nuclide in
 
a given organ or tissue to the concentration that would be obtained if
 
the same administered quantity of this nuclide were uniformly
 
distributed throughout the body.
 
Activation -- The process of inducing radioactivity by irradiation.
 
Activity -- The number of nuclear transformations occurring in a given
 
quantity of material per unit time. (See Curie.)
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Activity Median Aerodynamic Diameter (AMAD) -- The diameter of a unit-

density sphere with the same terminal settling velocity in air as that
 
of the aerosol particulate whose activity is the median for the entire
 
aerosol.
 
Acute Exposure -- Exposure to a chemical for a duration of 14 days or
 
less, as specified in the toxicological profiles.
 
Acute Radiation Syndrome -- The symptoms which taken together
 
characterize a person suffering from the effects of intense radiation.
 
The effects occur within hours or weeks.
 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical
 
adsorbed per unit weight of organic carbon in the soil or sediment to
 
the concentration of the chemical in solution at equilibrium.
 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment
 
or soil (i.e., the solid phase) divided by the amount of chemical in the
 
solution phase, which is in equilibrium with the solid phase, at a fixed
 
solid/solution ratio. It is generally expressed in micrograms of
 
chemical sorbed per gram of soil or sediment.
 
Alpha Particle -- A charged particle emitted from the nucleus of an
 
atom. An alpha particle has a mass charge equal in magnitude to that of
 
a helium nucleus; i.e., two protons and two neutrons and has a charge of
 
+2.
 
Annihilation (Electron) -- An interaction between a positive and a
 
negative electron in which they both disappear; their energy, including
 
rest energy, being converted into electromagnetic radiation (called
 
annihilation radiation) with two 0.51 Mev gamma photons emitted at an
 
angle of 180° to each other.
 
Atomic Mass -- The mass of a neutral atom of a nuclide, usually 
expressed in terms of "atomic mass units." The "atomic mass unit is 
one-twelfth the mass of one neutral atom of carbon-12; equivalent to 
1.6604x10-24 gm. (Symbol: u) 
Atomic Number -- The number of protons in the nucleus of a neutral atom
 
of a nuclide. The "effective atomic number" is calculated from the
 
composition and atomic numbers of a compound or mixture. An element of
 
this atomic number would interact with photons in the same way as the
 
compound or mixture. (Symbol: Z)
 
Atomic Weight -- The weighted mean of the masses of the neutral atoms of
 
an element expressed in atomic mass units.
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Auger Effect -- The emission of an electron from the extranuclear
 
portion of an excited atom when the atom undergoes a transition to a
 
less excited state.
 
Background Radiation -- Radiation arising from radioactive material
 
other than that under consideration. Background radiation due to cosmic
 
rays and natural radioactivity is always present. There may also be
 
background radiation due to the presence of radioactive substances in
 
building materials.
 
Becquerel (Bq) -- International System of Units unit of activity and
 
equals one transformation (disintegration) per second. (See Units.)
 
Beta Particle -- Charged particle emitted from the nucleus of an atom.
 
A beta particle has a mass and charge equal in magnitude to that of the
 
electron. The charge may be either +l or -1.
 
Biologic Effectiveness of Radiation -- (See Relative Biological
 
Effectiveness)
 
Bone Seeker -- Any compound or ion which migrates in the body
 
preferentially into bone.
 
Branching -- The occurrence of two or more modes by which a radionuclide 
can undergo radioactive decay. For example, radium C can undergo • or 
ß- decay, 64Cu can undergo ß-, ß+, or electron capture decay. An 
individual atom of a nuclide exhibiting branching disintegrates by one 
mode only. The fraction disintegrating by a particular mode is the 
"branching fraction" for that mode. The "branching ratio" is the ratio 
of two specified branching fractions (also called multiple 
disintegration). 
Bremsstrahlung -- The production of electromagnetic radiation (photons)
 
by the negative acceleration that a fast, charged particle (usually an
 
electron) undergoes from the effect of an electric or magnetic field,
 
for instance, from the field of another charged particle (usually a
 
nucleus).
 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or
 
group of studies, that produces significant increases in the incidence
 
of cancer (or tumors) between the exposed population and its appropriate
 
control.
 
Capture, Electron -- A mode of radioactive decay involving the capture
 
of an orbital electron by its nucleus. Capture from a particular
 
electron shell is designated as "K-electron capture," "L-electron
 
capture,II etc.
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Capture, K-Electron -- Electron capture from the K shell by the nucleus
 
of the atom. Also loosely used to designate any orbital electron
 
capture process.
 
Carcinogen -- A chemical capable of inducing cancer.
 
Carcinoma -- Malignant neoplasm composed of epithelial cells, regardless
 
of their derivation.
 
Cataract -- A clouding of the crystalline lens of the eye which
 
obstructs the passage of light.
 
Ceiling Value (DL) -- A concentration of a substance that should not be
 
exceeded, even instantaneously.
 
Chronic Exposure -- Exposure to a chemical for 365 days or more, as
 
specified in the Toxicological Profiles.
 
Compton Effect -- An attenuation process observed for x or gamma
 
radiation in which an incident photon interacts with an orbital electron
 
of an atom to produce a recoil electron and a scattered photon of energy
 
less than the incident photon.
 
Containment -- The confinement of radioactive material in such a way
 
that it is prevented from being dispersed into the environment or is
 
released only at a specified rate.
 
Contamination, Radioactive -- Deposition of radioactive material in any
 
place where it is not desired, particularly where its presence may be
 
harmful.
 
Cosmic Rays -- High-energy particulate and electromagnetic radiations
 
which originate outside the earth's atmosphere.
 
Count (Radiation Measurements) -- The external indication of a
 
radiation-measuring device designed to enumerate ionizing events. It
 
may refer to a single detected event to the total number registered in a
 
given period of time. The term often is erroneously used to designate a
 
disintegration, ionizing event, or voltage pulse.
 
Counter, Geiger-Mueller -- Highly sensitive, gas-filled
 
radiation-measuring device. It operates at voltages sufficiently
 
high to produce avalanche ionization.
 
Counter, Scintillation -- The combination of phosphor,
 
photmultiplier tube, and associated circuits for counting light
 
emissions produced in the phosphors by ionizing radiation.
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Curie – A unit of activity. One curie equals 3.7x1010 nuclear 
transformations per second. (Abbreviated Ci.) Several fractions of the 
curie are in common usage. 
Megacurie -- One million curies. Abbreviated MCi.
 
Microcurie -- One-millionth of a curie (3.7x104 disintegrations 
per sec). Abbreviated µCi.
 
Millicurie -- One-thousandth of a curie (3.7x107 disintegrations 
per set). Abbreviated mCi.
 
Nanocurie -- One-billionth of a curie. Abbreviated nCi.
 
Picocurie -- One-millionth of a microcurie (3.7x10-2 
disintegrations per second or 2.22 disintegrations per minute).
 
Abbreviated pCi; replaces the term µµc.
 
Decay, Radioactive -- Transformation of the nucleus of an unstable
 
nuclide by spontaneous emission of charged particles and/or photons.
 
Decay Chain or Decay Series -- A sequence of radioactive decays
 
(transformations) beginning with one nucleus. The initial nucleus, the
 
parent, decays into a daughter nucleus that differs from the first by
 
whatever particles were emitted during the decay. If further decays
 
take place, the subsequent nuclei are also usually called daughters.
 
Sometimes, to distinguish the sequence, the daughter of the first
 
daughter is called the granddaughter, etc.
 
Decay Constant -- The fraction of the number of atoms of a radioactive
 
nuclide which decay in unit time. (Symbol •). (See Disintegration
 
Constant).
 
Decay Product, Daughter Product -- A new isotope formed as a result of
 
radioactive decay. A nuclide resulting from the radioactive
 
transformation of a radionuclide, formed either directly or as the
 
result of successive transformations in a radioactive series. A decay
 
product (daughter product) may be either radioactive or stable.
 
Delta Ray -- Energetic or swiftly moving electrons ejected from an atom
 
during the process of ionization. Delta rays cause a track of secondary
 
ionizations along their path.
 
Developmental Toxicity -- The occurrence of adverse effects on the
 
developing organism that may result from exposure to a chemical prior to
 
conception (either parent), during prenatal development, or postnatally
 
to the time of sexual maturation. Adverse developmental effects may be
 
detected at any point in the lifespan of the organism.
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Disintegration Constant -- The fraction of the number of atoms of a 
radioactive nuclide which decay in unit time; 3, is the symbol for the 
decay constant in the equation N=Noe-λt where No is the initial number 
of atoms present, and N is the number of atoms present after some time, 
t. (See Decay Constant.)
 
Disintegration, Nuclear -- A spontaneous nuclear transformation
 
(radioactivity) characterized by the emission of energy and/or mass from
 
the nucleus. When large numbers of nuclei are involved, the process is
 
characterized by a definite half-life. (See Transformation, Nuclear.)
 
Dose -- A general term denoting the quantity of radiation or energy
 
absorbed. For special purposes it must be appropriately qualified. If
 
unqualified, it refers to absorbed dose.
 
Absorbed Dose -- The energy imparted to matter by ionizing
 
radiation per unit mass of irradiated material at the place of
 
interest. The unit of absorbed dose is the rad. One rad equals
 
100 ergs per gram. In SI units, the absorbed dose is the gray
 
which is 1 J/kg. (See Rad.)
 
Cumulative Dose (Radiation) -- The total dose resulting from
 
repeated or continuous exposures to radiation.
 
Dose Assessment -- An estimate of the radiation dose to an
 
individual or a population group usually by means of predictive
 
modeling techniques, sometimes supplemented by the results of
 
measurement.
 
Dose Equivalent (DE) -- A quantity used in radiation protection.
 
It expresses all radiations on a common scale for calculating the
 
effective absorbed dose. It is defined as the product of the
 
absorbed dose in rad and certain modifying factors. (The unit of
 
dose equivalent is the rem. In SI units, the dose equivalent is
 
the sievert, which equals 100 rem.)
 
Dose, Radiation -- The amount of energy imparted to matter by
 
ionizing radiation per unit mass of the matter, usually expressed
 
as the unit rad, or in SI units, 100 rad=l gray (Gy). (See
 
Absorbed Dose.)
 
Maximum Permissible Dose Equivalent (MPD) -- The greatest dose
 
equivalent that a person or specified part thereof shall be
 
allowed to receive in a given period of time.
 
Median Lethal Dose (MLD) -- Dose of radiation required to kill, 
within a specified period, 50 percent of the individuals in a 
large group of animals or organisms. Also called the LD50. 
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Threshold Dose -- The minimum absorbed dose that will produce a
 
detectable degree of any given effect.
 
Tissue Dose -- Absorbed dose received by tissue in the region of
 
interest, expressed in rad. (See Dose and Rad.)
 
Dose, Fractionation -- A method of administering radiation, in which
 
relatively small doses are given daily or at longer intervals.
 
Dose, Protraction -- A method of administering radiation by delivering
 
it continuously over a relatively long period at a low dose rate.
 
Dose-distribution Factor -- A factor which accounts for modification of
 
the dose effectiveness in cases in which the radionuclide distribution
 
is nonuniform.
 
Dose Rate -- Absorbed dose delivered per unit time.
 
Dosimetry -- Quantification of radiation doses to individuals or
 
populations resulting from specified exposures.
 
Early Effects (of radiation exposure) -- Effects which appear within 60
 
days of an acute exposure.
 
Electron -- A stable elementary particle having an electric charge equal 
to ±1.60210x10-19 C (Coulombs) and a rest mass equal to 9.1091x10-31 kg. 
A positron is a positively charged "electron." (See Positron.) 
Electron Volt -- A unit of energy equivalent to the energy gained by an 
electron in passing through a potential difference of one volt. Larger 
multiple units of the electron volt are frequently used: keV for 
thousand or kilo electron volts; MeV for million or mega electron volts. 
(Abbreviated: eV, 1 eV=1.6x10-12 erg.) 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as
 
a result of prenatal exposure to a chemical; the distinguishing feature
 
between the two terms is the stage of development during which the
 
insult occurred. The terms, as used here, include malformations and
 
variations, altered growth, and in utero death.
 
Energy -- Capacity for doing work. "Potential energy" is the energy 
inherent in a mass because of its spatial relation to other masses. 
"Kinetic energy" is the energy possessed by a mass because of its 
motion; MKSA unit: kg-m2/sec2 or joules. 
Binding Energy -- The energy represented by the difference in mass
 
between the sum of the component parts and the actual mass of the
 
nucleus.
 
96
 
9. GLOSSARY
 
Excitation Energy -- The energy required to change a system from
 
its ground state to an exited state. Each different excited state
 
has a different excitation energy.
 
Ionizing Energy -- The average energy lost by ionizing radiation
 
in producing an ion pair in a gas. For air, it is about 33.73 eV.
 
Radiant Energy -- The energy of electromagnetic radiation, such as
 
radio waves, visible light, x and gamma rays.
 
Enriched Material -- (1) Material in which the relative amount of one or 
more isotopes of a constituent has been increased. (2) Uranium in which 
the abundance of the 235U isotope is increased above normal. 
EPA Health Advisory -- An estimate of acceptable drinking water levels
 
for a chemical substance based on health effects information. A health
 
advisory is not a legally enforceable federal standard, but serves as
 
technical guidance to assist federal, state, and local officials.
 
Equilibrium, Radioactive -- In a radioactive series, the state which
 
prevails when the ratios between the activities of two or more
 
successive members of the series remains constant.
 
Secular Equilibrium -- If a parent element has a very much longer
 
half-life than the daughters (so there is not appreciable change
 
in its amount in the time interval required for later products to
 
attain equilibrium) then, after equilibrium is reached, equal
 
numbers of atoms of all members of the series disintegrate in unit
 
time. This condition is never exactly attained, but is
 
essentially established in such a case as radium and its series to
 
Radium D. The half-life of radium is about 1,600 years; of radon,
 
approximately 3.82 days, and of each of the subsequent members, a
 
few minutes. After about a month, essentially the equilibrium
 
amount of radon is present; then (and for a long time) all members
 
of the series disintegrate the same number of atoms per unit time.
 
Transient Equilibrium -- If the half-life of the parent is short
 
enough so the quantity present decreases appreciably during the
 
period under consideration, but is still longer than that of
 
successive members of the series, a stage of equilibrium will be
 
reached after which all members of the series decrease in activity
 
exponentially with the period of the parent. An example of this
 
is radon (half-life of approximately 3.82 days) and successive
 
members of the series to Radium D. Equilibrium, Radiation -- The
 
condition in a radiation field where the energy of the radiations
 
entering a volume equals the energy of the radiations leaving that
 
volume.
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Equilibrium Fraction (F) -- In radon-radon daughter equilibrium, the
 
parents and daughters have equal radioactivity, that is, as many decay
 
into a specific nuclide as decay out. However, if fresh radon is
 
continually entering a volume of air or if daughters are lost by
 
processes other than radioactive decay, e.g., plate out or migration out
 
of the volume, a disequilibrium develops. The equilibrium fraction is a
 
measure of the degree of equilibrium/disequilibrium. The working-level
 
definition of radon does not take into account the amount of
 
equilibrium. The equilibrium fraction is used to estimate working
 
levels based on measurement of radon only.
 
Excitation -- The addition of energy to a system, thereby transferring
 
it from its ground state to an excited state. Excitation of a nucleus,
 
an atom, or a molecule can result from absorption of photons or from
 
inelastic collisions with other particles. The excited state of an atom
 
is a metastable state and will return to ground state by radiation of
 
the excess energy.
 
Exposure -- A measure of the ionization produced in air by x or gamma
 
radiation. It is the sum of the electrical charges on all ions of one
 
sign produced in air when all electrons liberated by photons in a volume
 
element of air are completely stopped in air, divided by the mass of the
 
air in the volume element. The special unit of exposure is the
 
roentgen.
 
Fission, Nuclear -- A nuclear transformation characterized by the
 
splitting of a nucleus into at least two other nuclei and the release of
 
a relatively large amount of energy.
 
Gamma Ray -- Short wavelength electromagnetic radiation of nuclear
 
origin (range of energy from 10 keV to 9 MeV).
 
Genetic Effect of Radiation -- Inheritable change, chiefly mutations,
 
produced by the absorption of ionizing radiation by germ cells. On the
 
basis of present knowledge these effects are purely additive; there is
 
no recovery.
 
Gray (Gy) -- SI unit of absorbed dose. One gray equals 100 rad. (See
 
Units.)
 
Half-Life, Biological -- The time required for the body to eliminate
 
one-half of any absorbed substance by regular processes of elimination.
 
Approximately the same for both stable and radioactive isotopes of a
 
particular element. This is sometimes referred to as half-time.
 
Half-Life, Effective -- Time required for a radioactive element in an
 
animal body to be diminished 50% as a result of the combined action of
 
radioactive decay and biological elimination.
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Effective half-life: = Biological half-life x Radioactive half-life

 Biological half-life + Radioactive half-life
 
Half-life, Radioactive -- Time required for a radioactive substance to
 
lose 50% of its activity by decay. Each radionuclide has a unique halflife.
 
Immediately Dangerous to Life or Health (IDLH) -- The maximum
 
environmental concentration of a contaminant from which one could escape
 
within 30 minutes without any escape-impairing symptoms or irreversible
 
health effects.
 
Immunologic Toxicity -- The occurrence of adverse effects on the immune
 
system that may result from exposure to environmental agents such as
 
chemicals.
 
In Vitro -- Isolated from the living organism and artificially
 
maintained, as in a test tube.
 
In Vivo -- Occurring within the living organism.
 
Intensity -- Amount of energy per unit time passing through a unit area
 
perpendicular to the line of propagation at the point in question.
 
Intermediate Exposure -- Exposure to a chemical for a duration of 15 to
 
364 days as specified in the Toxicological Profiles.
 
Internal Conversion -- One of the possible mechanisms of decay from the
 
metastable state (isomeric transition) in which the transition energy is
 
transferred to an orbital electron, causing its ejection from the atom.
 
The ratio of the number of internal conversion electrons to the number
 
of gamma quanta emitted in the de-excitation of the nucleus is called
 
the "conversion ratio.II
 
Ion -- Atomic particle, atom, or chemical radical bearing a net
 
electrical charge, either negative or positive.
 
Ion Pair -- Two particles of opposite charge, usually referring to the
 
electron and positive atomic or molecular residue resulting after the
 
interaction of ionizing radiation with the orbital electrons of atoms.
 
Ionization -- The process by which a neutral atom or molecule acquires a
 
positive or negative charge.
 
Primary Ionization -- (1) In collision theory: the ionization
 
produced by the primary particles as contrasted to the "total
 
ionization" which includes the "secondary ionization" produced by
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delta rays. (2) In counter tubes: the total ionization produced
 
by incident radiation without gas amplification.
 
Specific Ionization -- Number of ion pairs per unit length of path
 
of ionizing radiation in a medium; e.g., per centimeter of air or
 
per micrometer of tissue.
 
Total Ionization -- The total electric charge of one sign on the
 
ions produced by radiation in the process of losing its kinetic
 
energy. For a given gas, the total ionization is closely
 
proportional to the initial ionization and is nearly independent
 
of the nature of the ionizing radiation. It is frequently used as
 
a measure of radiation energy.
 
Ionization Density -- Number of ion pairs per unit volume.
 
Ionization Path (Track) -- The trail of ion pairs produced by ionizing
 
radiation in its passage through matter.
 
Isobars -- Nuclides having the same mass number but different atomic
 
numbers.
 
Isomers -- Nuclides having the same number of neutrons and protons but
 
capable of existing, for a measurable time, in different quantum states
 
with different energies and radioactive properties. Commonly the isomer
 
of higher energy decays to one with lower energy by the process of
 
isomeric transition.
 
Isotones -- Nuclides having the same number of neutrons in their nuclei.
 
Isotopes -- Nuclides having the same number of protons in their nuclei,
 
and hence the same atomic number, but differing in the number of
 
neutrons, and therefore in the mass number. Almost identical chemical
 
properties exist between isotopes of a particular element. The term
 
should not be used as a synonym for nuclide.
 
Stable Isotope -- A nonradioactive isotope of an element.
 
Joule -- The unit for work and energy, equal to one newton expended
 
along a distance of one meter (lJ=lNxlm).
 
Labeled Compound -- A compound consisting, in part, of labeled
 
molecules. That is molecules including radionuclides in their
 
structure. By observations of radioactivity or isotopic composition,
 
this compound or its fragments may be followed through physical,
 
chemical, or biological processes.
 
  
100
 
9. GLOSSARY
 
Late Effects (of radiation exposure) -- Effects which appear 60 days or
 
more following an acute exposure.
 
Lethal Concentration (LO) (LCLO ) -- The lowest concentration of a chemical 
in air which has been reported to have caused death in humans or 
animals. 
Lethal Concentration (50) (LC50) -- The calculated concentration of a 
chemical in air to which exposure for a specific length of time is 
expected to cause death in 50% of a defined laboratory animal 
population. 
Lethal Dose (LO) (LDLO) -- The lowest dose of a chemical introduced by a 
route other than inhalation that is expected to have caused death in 
humans or animals. 
Lethal Dose (50) (LD50) -- The dose of a chemical which has been 
calculated to cause death in 50% of a defined laboratory animal 
population. 
Lethal Time (50) (LT50) -- A calculated period of time within which a 
specific concentration of a chemical is expected to cause death in 50% 
of a defined laboratory animal population. 
Linear Energy Transfer (LET) -- The average amount of energy transferred
 
locally to the medium per unit of particle track length.
 
Low-LET -- Radiation characteristic of electrons, x-rays, and
 
gamma rays.
 
High-LET -- Radiation characteristic of protons or fast neutrons.
 
Average LET -- is specified to even out the effect of a particle
 
that is slowing down near the end of its path and to allow for the
 
fact that secondary particles from photon or fast-neutron beams
 
are not all of the same energy.
 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of
 
chemical in a study, or group of studies, that produces statistically or
 
biologically significant increases in frequency or severity of adverse
 
effects between the exposed population and its appropriate control.
 
Linear Hypothesis -- The assumption that a dose-effect curve derived
 
from data in the high dose and high dose-rate ranges may be extrapolated
 
through the low dose and low dose range to zero, implying that,
 
theoretically, any amount of radiation will cause some damage.
 
101
 
9. GLOSSARY
 
Malformations -- Permanent structural changes in an organism that may
 
adversely affect survival, development, or function.
 
Mass Numbers -- The number of nucleons (protons and neutrons) in the
 
nucleus of an atom. (Symbol: A)
 
Minimal Risk Level -- An estimate of daily human exposure to a chemical
 
that is likely to be without an appreciable risk of deleterious effects
 
(noncancerous) over a specified duration of exposure.
 
Mutagen -- A substance that causes mutations. A mutation is a change in
 
the genetic material in a body cell. Mutation can lead to birth
 
defects, miscarriages, or cancer.
 
Neurotoxicity -- The occurrence of adverse effects on the nervous system
 
following exposure to chemical.
 
Neutrino -- A neutral particle of very small rest mass originally
 
postulated to account for the continuous distribution of energy among
 
particles in the beta-decay process.
 
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at
 
which there were no statistically or biologically significant increases
 
in frequency or severity of adverse effects seen between the exposed
 
population and its appropriate control. Effects may be produced at this
 
dose, but they are not considered to be adverse.
 
Nucleon -- Common name for a constituent particle of the nucleus.
 
Applied to a proton or neutron.
 
Nuclide -- A species of atom characterized by the constitution of its
 
nucleus. The nuclear constitution is specified by the number of protons
 
(Z) number of neutrons (N), and energy content; or, alternatively, by
 
the atomic number (Z), mass number A=(N+Z), and atomic mass. To be
 
regarded as a distinct nuclide, the atom must be capable of existing for
 
a measurable time. Thus, nuclear isomers are separate nuclides, whereas
 
promptly decaying excited nuclear states and unstable intermediates in
 
nuclear reactions are not so considered.
 
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of
 
the concentrations of a chemical in n-octanol and water, in dilute
 
solution.
 
Pair Production -- An absorption process for x and gamma radiation in
 
which the incident photon is annihilated in the vicinity of the nucleus
 
of the absorbing atom, with subsequent production of an electron and
 
positron pair. This reaction only occurs for incident photon energies
 
exceeding 1.02 MeV.
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Parent -- A radionuclide which, upon disintegration, yields a spec ified
 
nuclide--either directly or as a later member of a radioactive series.
 
Photon -- A quantity of electromagnetic energy (E) whose value in joules
 
is the product of its frequency (v) in hertz and Planck constant (h).
 
The equation is: E=hv.
 
Photoelectric Effect -- An attenuation process observed for x- and
 
gamma- radiation in which an incident photon interacts with an orbital
 
electron of an atom delivering all of its energy to produce a recoil
 
electron, but with no scattered photon.
 
Positron -- Particle equal in mass to the electron (9.1091x10-31 kg) and 
having an equal but positive charge (+1.60210x10-19 Coulombs). (See 
Electron). 
Potential Ionization -- The potential necessary to separate one electron
 
from an atom, resulting in the formation of an ion pair.
 
Power, Stopping -- A measure of the effect of a substance upon the
 
kinetic energy of a charged particle passing through it.
 
Progeny -- The decay products resulting after a series of radioactive
 
decays. Progeny can also be radioactive, and the chain continues until
 
a stable nuclide is formed.
 
Proton -- Elementary nuclear particle with a positive electric charge
 
equal numerically to the charge of the electron and a rest mass of
 
1.007277 mass units.
 
q1* -- The upper-bound estimate of the low-dose slope of the doseresponse 
curve as determined by the multistage procedure. The q1* can 
be used to calculate an estimate of carcinogenic potency, the 
incremental excess cancer risk per unit of exposure (usually µg/L for 
water, mg/kg/day for food, and ,µg/m3 for air). 
Quality -- A term describing the distribution of the energy deposited by
 
a particle along its track; radiations that produce different densities
 
of ionization per unit intensity are said to have different "qualities."
 
Quality Factor (QF) -- The linear-energy-transfer-dependent factor by
 
which absorbed doses are multiplied to obtain (for radiation protection
 
purposes) a quantity that expresses - on a common scale for all ionizing
 
radiation - the effectiveness of the absorbed dose.
 
Rad -- The unit of absorbed dose equal to 0.01 J/kg in any medium. (See
 
Absorbed Dose.)
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Radiation -- (1) The emission and propagation of energy through space or
 
through a material medium in the form of waves; for instance, the
 
emission and propagation of electromagnetic waves, or of sound and
 
elastic waves. (2) The energy propagated through space or through a
 
material medium as waves; for example, energy in the form of
 
electromagnetic waves or of elastic waves. The term radiation or
 
radiant energy, when unqualified, usually refers to electro-magnetic
 
radiation. Such radiation commonly is classified, according to
 
frequency, as Hertzian, infra-red, visible (light), ultra-violet, X-ray
 
and gamma ray. (See Photon.) (3) By extension, corpuscular emission,
 
such as alpha and beta radiation, or rays of mixed or unknown type, as
 
cosmic radiation.
 
Annihilation Radiation -- Photons produced when an electron and a
 
positron unite and cease to exist. The annihilation of a
 
positron-electron pair results in the production of two photons,
 
each of 0.51 MeV energy.
 
Background Radiation -- Radiation arising from radioactive
 
material other than the one directly under consideration.
 
Background radiation due to cosmic rays and natural radioactivity
 
is always present. There may also be background radiation due to
 
the presence of radioactive substances in other parts of the
 
building, in the building material itself, etc.
 
Characteristic (Discrete) Radiation -- Radiation originating from
 
an atom after removal of an electron of excitation of the nucleus,
 
The wavelength of the emitted radiation is specific, depending
 
only on the nuclide and particular energy levels involved.
 
External Radiation -- Radiation from a source outside the body -­
the radiation must penetrate the skin.
 
Internal Radiation -- Radiation from a source within the body (as
 
a result of deposition of radionuclides in body tissues).
 
Ionizing Radiation -- Any electromagnetic or particulate radiation
 
capable of producing ions, directly or indirectly, in its passage
 
through matter.
 
Monoenergetic Radiation -- Radiation of a given type (alpha, beta,
 
neutron, gamma, etc.) in which all particles or photons originate
 
with and have the same energy.
 
Scattered Radiation -- Radiation which during its passage through
 
a substance, has been deviated in direction. It may also have
 
been modified by a decrease in energy.
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Secondary Radiation -- Radiation that results from absorption of
 
other radiation in matter. It may be either electromagnetic or
 
particulate.
 
Radioactivity -- The property of certain nuclides to spontaneously emit
 
particles or gamma radiation or x radiation following orbital electron
 
capture or after undergoing spontaneous fission.
 
Artificial Radioactivity -- Man-made radioactivity produced by
 
particle bombardment or electromagnetic irradiation, as opposed to
 
natural radioactivity.
 
Induced Radioactivity -- Radioactivity produced in a substance
 
after bombardment with neutrons or other particles. The resulting
 
activity is "natural radioactivity" if formed by nuclear reactions
 
occurring in nature, and "artificial radioactivity" if the
 
reactions are caused by man.
 
Natural Radioactivity -- The property of radioactivity exhibited
 
by more than 50 naturally occurring radionuclides.
 
Radioisotopes -- A radioactive atomic species of an element with the
 
same atomic number and usually identical chemical properties.
 
Radionuclide -- A radioactive species of an atom characterized by the
 
constitution of its nucleus.
 
Radiosensitivity -- Relative susceptibility of cells, tissues, organs,
 
organisms, or any living substance to the injurious action of radiation.
 
Radiosensitivity and its antonym, radioresistance, are currently used in
 
a comparative sense, rather than in an absolute one.
 
Reaction (Nuclear) -- An induced nuclear disintegration, i.e., a process
 
occurring when a nucleus comes in contact with a photon, an elementary
 
particle, or another nucleus. In many cases the reaction can be
 
represented by the symbolic equation: X+a→Y+b or, in abbreviated form, 
X(a,b) Y. X is the target nucleus, a is the incident particle or 
photon, b is an emitted particle or photon, and Y is the product 
nucleus. 
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps
 
an order of magnitude) of the daily exposure of the human population to
 
a potential hazard that is likely to be without risk of deleterious
 
effects during a lifetime. The RfD is operationally derived from the
 
NOAEL (from animal and human studies) by a consistent application of
 
uncertainty factors that reflect various types of data used to estimate
 
RfDs and an additional modifying factor, which is based on a
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professional judgment of the entire database on the chemical. The RfDs
 
are not applicable to nonthreshold effects such as cancer.
 
Relative Biological Effectiveness (RBE) -- The RBE is a factor used to
 
compare the biological effectiveness of absorbed radiation doses (i.e.,
 
rad) due to different types of ionizing radiation. More specifically,
 
it is the experimentally determined ratio of an absorbed dose of a
 
radiation in question to the absorbed dose of a reference radiation
 
required to produce an identical biological effect in a particular
 
experimental organism or tissue. NOTE: This term should not be used in
 
radiation protection. (See Quality Factor.)
 
Rem -- A unit of dose equivalent. The dose equivalent in rem is
 
numerically equal to the absorbed dose in rad multiplied by the quality
 
factor, the distribution factor, and any other necessary modifying
 
factors.
 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that
 
is considered reportable under CERCIA. Reportable quantities are (1) 1
 
lb or greater or (2) for selected substances, an amount established by
 
regulation either under CERCLA or under Section 311 of the Clean Water
 
Act. Quantities are measured over a 24-hour period.
 
Reproductive Toxicity -- The occurrence of adverse effects on the
 
reproductive system that may result from exposure to a chemical. The
 
toxicity may be directed to the reproductive organs and/or the related
 
endocrine system. The manifestation of such toxicity may be noted as
 
alterations in sexual behavior, fertility, pregnancy outcomes, or
 
modifications in other functions that are dependent on the integrity of
 
this system.
 
Roentgen (R) -- A unit of exposure for photon radiation. One roentgen
 
equals 2.58x10-4 Coulomb per kilogram of air.
 
Short-Term Exposure Limit (STEL) -- The maximum concentration to which
 
workers can be exposed continually for up to 15 minutes. No more than
 
four excursions are allowed per day, and there must be at least 60
 
minutes between exposure periods. The daily TLV-TWA may not be
 
exceeded.
 
SI Units -- The International System of Units as defined by the General
 
Conference of Weights and Measures in 1960. These units are generally
 
based on the meter/kilogram/second units, with special quantities for
 
radiation including the becquerel, gray, and sievert.
 
Sickness, Radiation -- (Radiation Therapy): A self-limited syndrome
 
characterized by nausea, vomiting, diarrhea, and psychic depression
 
following exposure to appreciable doses of ionizing radiation,
 
106
 
9. GLOSSARY
 
particularly to the abdominal region. Its mechanism is unknown and
 
there is no satisfactory remedy. It usually appears a few hours after
 
irradiation and may subside within a day. It may be sufficiently severe
 
to necessitate interrupting the treatment series or to incapacitate the
 
patient. (General): The syndrome associated with intense acute
 
exposure to ionizing radiations. The rapidity with which symptoms
 
develop is a rough measure of the level of exposure.
 
Sievert -- The SI unit of radiation dose equivalent. It is equal to
 
dose in grays times a quality factor times other modifying factors, for
 
example, a distribution factor; 1 sievert equals 100 rem.
 
Specific Activity -- Total activity of a given nuclide per gram of an
 
element.
 
Specific Energy -- The actual energy per unit mass deposited per unit
 
volume in a given event. This is a stochastic quantity as opposed to
 
the average value over a large number of instance (i.e., the absorbed
 
dose).
 
Standard Mortality Ratio (SMR) -- Standard mortality ratio is the ratio
 
of the disease or accident mortality rate in a certain specific
 
population compared with that in a standard population. The ratio is
 
based on 200 for the standard so that an SMR of 100 means that the test
 
population has twice the mortality from that particular cause of death.
 
Stopping Power -- The average rate of energy loss of a charged particle
 
per unit thickness of a material or per unit mass of material traversed.
 
Surface-seeking Radionuclide -- A bone-seeking internal emitter that is
 
deposited and remains on the surface for a long period of time. This
 
contrasts with a volume seeker, which deposits more uniformly throughout
 
the bone volume.
 
Target Organ Toxicity -- This term covers a broad range of adverse
 
effects on target organs or physiological systems (e.g., renal,
 
cardiovascular) extending from those arising through a single limited
 
exposure to those assumed over a lifetime of exposure to a chemical.
 
Target Theory (Hit Theory) -- A theory explaining some biological
 
effects of radiation on the basis that ionization, occurring in a
 
discrete volume (the target) within the cell, directly causes a lesion
 
which subsequently results in a physiological response to the damage at
 
that location. One, two, or more "hits" (ionizing events within the
 
target) may be necessary to elicit the response.
 
Teratogen -- A chemical that causes structural defects that affect the
 
development of a fetus.
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Working Level (WL) -- Any combination of short-lived radon daughters in 
1 liter of air that will result in the ultimate emission of 1.3x105 MeV 
of potential alpha energy. 
Working Level Month (WLM) -- Inhalation of air with a concentration of 1
 
WL of radon daughters for 170 working hours results in an exposure of 1
 
WLM.
 
X-rays -- Penetrating electromagnetic radiations whose wave lengths are
 
shorter than those of visible light. They are usually produced by
 
bombarding a metallic target with fast electrons in a high vacuum. In
 
nuclear reaction, it is customary to refer to photons originating in the
 
extranuclear part of the atom as X-rays. These rays are sometimes
 
called roentgen rays after their discoverer, W.C. Roentgen.
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PEER REVIEW
 
A peer review panel was assembled for radium. The panel consisted of
 
the following members: Dr. Carmia Borek, Professor of Pathology,
 
Columbia University; Dr. Douglas Crawford-Brown, Assistant Professor in
 
the Department of Environmental Science, University of North Carolina;
 
Dr. Haluk Ozkaynak, Lecturer, Harvard School of Public Health, Research
 
Fellow, Energy and Environmental Policy Center, Kennedy School of
 
Government, Harvard University; Dr. Ray Lloyd, Research Professor,
 
Radiobiology Division, University of Utah. These experts collectively
 
have knowledge of radium's physical and chemical properties,
 
toxicokinetics, key health end points, mechanisms of action, human and
 
animal exposure, and quantification of risk to humans. All reviewers
 
were selected in conformity with the conditions for peer review
 
specified in Section 104(i)(13) of the Comprehensive Environmental
 
Response, Compensation, and Liability Act, as amended.
 
A joint panel of scientists from ATSDR and EPA has reviewed the peer
 
reviewers' comments and determined which comments will be included in
 
the profile. A listing of the peer reviewers' comments not incorporated
 
in the profile, with a brief explanation of the rationale for their
 
exclusion, exists as part of the administrative record for this
 
compound. A list of databases reviewed and a list of unpublished
 
documents cited are also included in the administrative record.
 
The citation of the peer review panel should not be understood to
 
imply their approval of the profile's final content. The responsibility
 
for the content of this profile lies with the Agency for Toxic
 
Substances and Disease Registry.
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OVERVIEW OF BASIC RADIATION PHYSICS, CHEMISTRY AND BIOLOGY
 
Understanding the basic concepts in radiation physics, chemistry,
 
and biology is important to the evaluation and interpretation of
 
radiation-induced adverse health effects and to the derivation of
 
radiation protection principles. This appendix presents a brief
 
overview of the areas of radiation physics, chemistry, and biology and
 
is based to a large extent on the reviews of Mettler and Moseley (1985),
 
Hobbs and McClellan (1986), Eichholz (1982), Hendee (1973), and Early et
 
al. (1979).
 
B.l RADIONUCLIDES AND RADIOACTIVITY
 
The substances we call elements are composed of atoms. Atoms in
 
turn are made up of neutrons, protons, and electrons; neutrons and
 
protons in the nucleus and electrons in a cloud of orbits around the
 
nucleus. Nuclide is the general term referring to any nucleus along
 
with its orbital electrons. The nuclide is characterized by the
 
composition of its nucleus and hence by the number of protons and
 
neutrons in the nucleus. All atoms of an element have the same number
 
of protons (this is given by the atomic number) but may have different
 
numbers of neutrons (this is reflected by the atomic mass or atomic
 
weight of the element). Atoms with different atomic mass but the same
 
atomic numbers are referred to as isotopes of an element.
 
The numerical combination of protons and neutrons in most nuclides
 
is such that the atom is said to be stable; however, if there are too
 
few or too many neutrons, the nucleus of the atom is unstable. Unstable
 
nuclides undergo a process referred to as radioactive transformation in
 
which energy is emitted. These unstable atoms are called radionuclides;
 
their emissions are called ionizing radiation; and the whole property is
 
called radioactivity. Transformation or decay results in the formation
 
of new nuclides some of which may themselves be radionuclides, while
 
others are stable nuclides. This series of transformations is called
 
the decay chain of the radionuclide. The first radionuclide in the
 
chain is called the parent; the subsequent products of the
 
transformation are called progeny, daughters, or decay products.
 
In general there are two classifications of radioactivity and
 
radionuclides: natural and man-made. Naturally-occurring radionuclides
 
exist in nature and no additional energy is necessary to place them in
 
an unstable state. Natural radioactivity is the property of some
 
naturally occurring, usually heavy elements, that are heavier than lead.
 
Radionuclides, such as radium and uranium, primarily emit alpha
 
particles. Some lighter elements such as carbon-14 and tritium
 
(hydrogen-3) primarily emit beta particles as they transform to a more
 
stable atom. Natural radioactive atoms heavier than lead cannot attain
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a stable nucleus heavier than lead. Everyone is exposed to background
 
radiation from naturally-occurring radionuclides throughout life. This
 
background radiation is the major source of radiation exposure to man
 
and arises from several sources. The natural background exposures are
 
frequently used as a standard of comparison for exposures to various
 
man-made sources of ionizing radiation.
 
Man-made radioactive atoms are produced either as a by-product of
 
fission of uranium atoms in a nuclear reactor or by bombarding stable
 
atoms with particles, such as neutrons, directed at the stable atoms
 
with high velocity. These artificially produced radioactive elements
 
usually decay by emission of particles, such as positive or negative
 
beta particles and one or more high energy photons (gamma rays).
 
Unstable (radioactive) atoms of any element can be produced.
 
Both naturally occurring and man-made radioisotopes find
 
application in medicine, industrial products, and consumer products.
 
Some specific radioisotopes, called fall-out, are still found in the
 
environment as a result of nuclear weapons use or testing.
 
B.2 RADIOACTIVE DECAY
 
B.2.1 Principles of Radioactive Decay
 
The stability of an atom is the result of the balance of the forces
 
of the various components of the nucleus. An atom that is unstable
 
(radionuclide) will release energy (decay) in various ways and transform
 
to stable atoms or to other radioactive species called daughters, often
 
with the release of ionizing radiation. If there are either too many or
 
too few neutrons for a given number of protons, the resulting nucleus
 
may undergo transformation. For some elements, a chain of daughter
 
decay products may be produced until stable atoms are formed.
 
Radionuclides can be characterized by the type and energy of the
 
radiation emitted, the rate of decay, and the mode of decay. The mode
 
of decay indicates how a parent compound undergoes transformation.
 
Radiations considered here are primarily of nuclear origin, i.e., they
 
arise from nuclear excitation, usually caused by the capture of charged
 
or uncharged nucleons by a nucleus, or by the radioactive decay or
 
transformation of an unstable nuclide. The type of radiation may be
 
categorized as charged or uncharged particles (electrons, neutrons,
 
neutrinos, alpha particles, beta particles, protons, and fission
 
products) or electromagnetic radiation (gamma rays and X-rays). Table
 
B-l summarizes the basic characteristics of the more common types of
 
radiation encountered.
 
B.2.2 Half-Life and Activity
 
For any given radionuclide, the rate of decay is a first-order
 
process that depends on the number of radioactive atoms present and is
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characteristic for each radionuclide. The process of decay is a series of
 
random events; temperature, pressure, or chemical combinations do not effect
 
the rate of decay. While it may not be possible to predict exactly which atom
 
is going to undergo transformation at any given time, it is possible to
 
predict, on the average, how many atoms will transform during any interval of
 
time.
 
The source strength is a measure of the rate of emission of radiation.
 
For these radioactive materials it is customary to describe the source
 
strength in terms of the source activity, which is defined as the number of
 
disintegrations (transformations) per unit time occurring in a given quantity
 
of this material. The unit of activity is the curie (Ci) which was originally
 
related to the activity of one gram of radium, but is now defined as:
 
1 curie (Ci) = 3.7x1010 disintegrations (transformations)/second (dps) or
 
2.22x1012 disintegrations (transformations)/minute (dpm).
 
The SI unit of activity is the becquerel (Bq); 1 Bq = 1 transformation/second.
 
Since activity is proportional to the number of atoms of the radioactive 
material, the quantity of any radioactive material is usually expressed in 
curies, regardless of its purity or concentration. The transformation of 
radioactive nuclei is a random process, and the rate of transformation is 
directly proportional to the number of radioactive atoms present. For any 
pure radioactive substance, the rate of decay is usually described by its 
radiological half-life, TR, i.e., the time it takes for a specified source 
material to decay to half its initial activity. 
The activity of a radionuclide at time t may be calculated by:
 
-0.693t/T
A = A e

o rad
 
where A is the activity in dps, A
o
 is the activity at time zero, t is the time
 
at which measured, and T
rad is the radiological half-life of the radionuclide.
 
It is apparent that activity exponentially decays with time. The time when
 
the activity of a sample of radioactivity becomes one-half its original value
 
is the radioactive half-life and is expressed in any suitable unit of time.
 
The specific activity is the radioactivity per unit weight of material.
 
This activity is usually expressed in curies per gram and may be calculated by
 
curies/gram = l.3x108/(T
rad)(atomic weight)
 
where T
rad is the radiological half-life in days.
 
In the case of radioactive materials contained in living organisms, an
 
additional consideration is made for the reduction in observed activity due to
 
regular processes of elimination of the respective chemical or biochemical
 
substance from the organism. This introduces a rate constant called the
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biological half-life (Tbiol) which is the time required for biological 
processes to eliminate one-half of the activity. This time is virtually the
 
same for both stable and radioactive isotopes of any given element.
 
Under such conditions the time required for a radioactive element to be
 
halved as a result of the combined action of radioactive decay and biological
 
elimination is the effective half-life:
 
Teff = (Tbiol x Trad)/(Tbiol + Trad). 
Table B-2 presents representative effective half-lives of particular interest.
 
B.2.3 Interaction of Radiation with Matter
 
Both ionizing and nonionizing radiation will interact with materials,
 
that is, it will lose kinetic energy to any solid, liquid or gas through which
 
it passes by a variety of mechanisms. The transfer of energy to a medium by
 
either electromagnetic or particulate radiation may be sufficient to cause
 
formation of ions. This process is called ionization. Compared to other
 
types of radiation that may be absorbed, such as ultraviolet radiation,
 
ionizing radiation deposits a relatively large amount of energy into a small
 
volume.
 
The method by which incident radiation interacts with the medium to cause
 
ionization may be direct or indirect. Electromagnetic radiations (X-rays and
 
gamma photons) are indirectly ionizing; that is, they give up their energy in
 
various interactions with cellular molecules, and the energy is then utilized
 
to produce a fast-moving charged particle such as an electron. It is the
 
electron that then secondarily may react with a target molecule. Charged
 
particles, in contrast, strike the tissue or medium and directly react with
 
target molecules, such as oxygen or water. These particulate radiations are
 
directly ionizing radiations. Examples of directly ionizing particles include
 
alpha and beta particles. Indirectly ionizing radiations are always more
 
penetrating than directly ionizing particulate radiations.
 
Mass, charge, and velocity of a particle all affect the rate at which
 
ionization occurs. The higher the charge of the particle and the lower the
 
velocity, the greater the propensity to cause ionization. Heavy, highly
 
charged particles, such as alpha particles, lose energy rapidly with distance
 
and, therefore, do not penetrate deeply. The result of these interaction
 
processes is a gradual slowing down of any incident particle until it is
 
brought to rest or "stopped" at the end of its range.
 
B-2.4 Characteristics of Emitted Radiation
 
B.2.4.1 Alpha Emission. In alpha emission, an alpha particle consisting
 
of two protons and two neutrons is emitted with a resulting decrease in the
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atomic mass number by four and reduction of the atomic number by two, thereby
 
changing the parent to a different element. The alpha particle is identical
 
to a helium nucleus consisting of two neutrons and two protons. It results
 
from the radioactive decay of some heavy elements such as uranium, plutonium,
 
radium, thorium, and radon. Alpha particles have a large mass as compared to
 
electrons. Decay of alpha-emitting radionuclides may result in the emission
 
of several different alpha particles. A radionuclide has an alpha emission
 
with a discrete alpha energy and characteristic pattern of alpha energy
 
emitted.
 
The alpha particle has an electrical charge of +2. Because of this
 
double positive charge, alpha particles have great ionizing power, but their
 
large size results in very little penetrating power. In fact, an alpha
 
particle cannot penetrate a sheet of paper. The range of an alpha particle,
 
that is, the distance the charged particle travels from the point of origin to
 
its resting point, is about 4 cm in air, which decreases considerably to a few
 
micrometers in tissue. These properties cause alpha emitters to be hazardous
 
only if there is internal contamination (i.e., if the radionuclide is
 
ingested, inhaled, or otherwise absorbed).
 
B.2.4.2. Beta Emission. Nuclei which are excessively neutron rich decay
 
by B-decay. A beta particle (ß) is a high-velocity electron ejected from a
 
disintegrating nucleus. The particle may be either a negatively charged
 
electron, termed a negatron (ß-) or a positively charged electron, termed a
 
positron (R+). Although the precise definition of "beta emission" refers to
 
both fi- and D+, common usage of the term generally applies only to the
 
negative particle, as distinguished from the positron emission, which refers
 
to the 13+ particle.
 
B.2.4.2.1 Beta Negative Emission. Beta particle (ß-) emission is
 
another process by which a radionuclide, usually those with a neutron excess,
 
achieves stability. Beta particle emission decreases the number of neutrons
 
by one and increases the number of protons by one, while the atomic mass
 
remains unchanged. This transformation results in the formation of a
 
different element. The energy spectrum of beta particle emission ranges from
 
a certain maximum down to zero with the mean energy of the spectrum being
 
about one-third of the maximum. The range in tissue is much less. Beta
 
negative emitting radionuclides can cause injury to the skin and superficial
 
body tissues but mostly present an internal contamination hazard.
 
B-2.4.2.2 Positron Emission. In cases in which there are too many
 
protons in the nucleus, positron emission may occur. In this case a proton
 
may be thought of as being converted into a neutron, and a positron (ß+) is
 
emitted, accompanied by a neutrino (see glossary). This increases the number
 
of neutrons by one, decreases the number of protons by one, and again leaves
 
the atomic mass unchanged. The gamma radiation resulting from the
 
annihilation (see glossary) of the positron makes all positron emitting
 
isotopes more of an external radiation hazard than pure 13 emitters of equal
 
energy.
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B.2.4.2.3 Gamma Emission. Radioactive decay by alpha, beta, positron
 
emission or electron capture often leaves some of the energy resulting from
 
these changes in the nucleus. As a result, the nucleus is raised to an
 
excited level. None of these excited nuclei can remain in this high-energy
 
state. Nuclei release this energy returning to ground state or to the lowest
 
possible stable energy level. The energy released is in the form of gamma
 
radiation (high energy photons) and has an energy equal to the change in the
 
energy state of the nucleus. Gamma and X-rays behave similarly but differ in
 
their origin; gamma emissions originate in the nucleus while X-rays originate
 
in the orbital electron structure.
 
B.3 ESTIMATION OF ENERGY DEPOSITION IN HUMAN TISSUES
 
Two forms of potential radiation exposures can result -- internal and
 
external. The term exposure denotes physical interaction of the radiation
 
emitted from the radioactive material with cells and tissues of the human
 
body. An exposure can be "acute" or "chronic" depending on how long an
 
individual or organ is exposed to the radiation. Internal exposures occur
 
when radionuclides, which have entered the body (e.g., through the inhalation,
 
ingestion, or dermal pathways), undergo radioactive decay resulting in the
 
deposition of energy to internal organs. External exposures occur when
 
radiation enters the body directly from sources located outside the body, such
 
as radiation emitters from radionuclides on ground surfaces, dissolved in
 
water, or dispersed in the air. In general, external exposures are from
 
material emitting gamma radiation, which readily penetrate the skin and
 
internal organs. Beta and alpha radiation from external sources are far less
 
penetrating and deposit their energy primarily on the skin's outer layer.
 
Consequently, their contribution to the absorbed dose of the total body dose,
 
compared to that deposited by gamma rays, may be negligible.
 
Characterizing the radiation dose to persons as a result of exposure to
 
radiation is a complex issue. It is difficult to: (1) measure internally the
 
amount of energy actually transferred to an organic material and to correlate
 
any observed effects with this energy deposition; and (2) account for and
 
predict secondary processes, such as collision effects or biologically
 
triggered effects, that are an indirect consequence of the primary interaction
 
event.
 
B.3.1 Dose Units
 
B.3.1.1 Roentgen. The roentgen (R) is a unit of exposure related to the 
amount of ionization caused in air by gamma or x-radiation. One roentgen 
equals 2.58x10-4 Coulomb per kilogram of air. In the case of gamma radiation, 
over the commonly encountered range of photon energy, the energy deposition in 
tissue for a dose of 1 R is about 0.0096 joules(J)/kg of tissue. 
B.3.1.2 Absorbed Dose and Absorbed Dose Rate. Since different types of
 
radiation interact differently with any material through which they pass, any
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attempt to assess their effect on humans or animals should take into account
 
these differences. The absorbed dose is defined as the energy imparted by the
 
incident radiation to a unit mass of the tissue or organ. The unit of
 
absorbed dose is the rad; 1 rad = 100 erg/gram = 0.01 J/kg in any medium. The
 
SI unit is the gray which is equivalent to 100 rad or 1 J/kg. Internal and
 
external exposures from radiation sources are not usually instantaneous but
 
are distributed over extended periods of time. The resulting rate of change
 
of the absorbed dose to a small volume of mass is referred to as the absorbed
 
dose rate in units of rad/unit time.
 
B.3.1.3 Working Levels and Working Level Months. Working levels are 
units that have been used to describe the radon decay-product activities in 
air in terms of potential alpha energy. It is defined as any combination of 
short-lived radon daughters (through polonium-214) per liter of air that will 
result in the emission of 1.3x105 MeV of alpha energy. An activity 
concentration of 100 pCi radon-222/L of air, in equilibrium with its 
daughters, corresponds approximately to a potential alpha-energy concentration 
of 1 WL. The WL unit can also be used for thoron daughters. In this case, 
1.3x105 MeV of alpha energy (1 WL) is released by the thoron daughters in 
equilibrium with 7.5 pCi thoron/L. The potential alpha energy exposure of 
miners is commonly expressed in the unit Working Level Month (WIN). One WLM 
corresponds to exposure to a concentration of 1 WL for the reference period of 
170 hours. 
B.3.2 Dosimetry Models
 
Dosimetry models are used to estimate the internally deposited dose from
 
exposure to radioactive substances. The models for internal dosimetry
 
consider the quantity of radionuclides entering the body, the factors
 
affecting their movement or transport through the body, distribution and
 
retention of radionuclides in the body, and the energy deposited in organs and
 
tissues from the radiation that is emitted during spontaneous decay processes.
 
The models for external dosimetry consider only the photon doses to organs of
 
individuals who are immersed in air or are exposed to a contaminated ground
 
surface. The dose pattern for radioactive materials in the body may be
 
strongly influenced by the route of entry of the material. For industrial
 
workers, inhalation of radioactive particles with pulmonary deposition and
 
puncture wounds with subcutaneous deposition have been the most frequent. The
 
general population has been exposed via ingestion and inhalation of low levels
 
of naturally occurring radionuclides as well as man-produced radionuclides
 
from nuclear weapons testing.
 
B.3.2.1 Ingestion. Ingestion of radioactive materials is most likely to
 
occur from contaminated foodstuffs or water or eventual ingestion of inhaled
 
compounds initially deposited in the lung. Ingestion of radioactive material
 
may result in toxic effects as a result of either absorption of the
 
radionuclide or irradiation of the gastrointestinal tract during passage
 
through the tract, or a combination of both. The fraction of a radioactive
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material absorbed from the gastrointestinal tract is variable, depending on
 
the specific element, the physical and chemical form of the material ingested,
 
and the diet, as well as some other metabolic and physiological factors. The
 
absorption of some elements is influenced by age usually with higher
 
absorption in the very young.
 
B.3.2.2 Inhalation. The inhalation route of exposure has long been
 
recognized as being of major importance for both nonradioactive and
 
radioactive materials. The deposition of particles within the lung is largely
 
dependent upon the size of the particles being inhaled. After the particle is
 
deposited, the retention will depend upon the physical and chemical properties
 
of the dust and the physiological status of the lung. The retention of the
 
particle in the lung depends on the location of deposition, in addition to the
 
physical and chemical properties of the particles. The converse of pulmonary
 
retention is pulmonary clearance. There are three distinct mechanisms of
 
clearance which operate simultaneously. Giliary clearance acts only in the
 
upper respiratory tract. The second and third mechanisms act mainly in the
 
deep respiratory tract. These are phagocytosis and absorption. Phagocytosis
 
is the engulfing of foreign bodies by alveolar macrophages and their
 
subsequent removal either up the ciliary "escalator" or by entrance into the
 
lymphatic system. Some inhaled soluble particulates are absorbed into the
 
blood and translocated to other organs and tissues. Dosimetric lung models
 
are reviewed by James (1987) and James and Roy (1987).
 
B.3.3 Internal Emitters
 
The absorbed dose from internally deposited radioisotopes is the energy
 
absorbed by the surrounding tissue. For a radioisotope distributed uniformly
 
throughout an infinitely large medium, the concentration of absorbed energy
 
must be equal to the concentration of energy emitted by the isotope. An
 
infinitely large medium may be approximated by a tissue mass whose dimensions
 
exceed the range of the particle. All alpha and most beta radiation will be
 
absorbed in the organ (or tissue) of reference. Gamma-emitting isotope
 
emissions are penetrating radiation and a substantial fraction may travel
 
great distances within tissue, leaving the tissue without interacting. The
 
dose to an organ or tissue is a function of the effective retention half-time,
 
the energy released in the tissue, the amount of radioactivity initially
 
introduced, and the mass of the organ or tissue.
 
B.4 BIOLOGICAL EFFECTS OF RADIATION
 
When biological material is exposed to ionizing radiation, a chain of
 
cellular events occurs as the ionizing particle passes through the biological
 
material. A number of theories have been proposed to describe the interaction
 
of radiation with biologically important molecules in cells and to explain the
 
resulting damage to biological systems from those interactions. Many factors
 
may modify the response of a living organism to a given dose of radiation.
 
Factors related to the exposure include the dose rate, the energy of the
 
121
 
APPENDIX B
 
radiation, and the temporal pattern of the exposure. Biological
 
considerations include factors such as species, age, sex, and the portion of
 
the body exposed. Several excellent reviews of the biological effects of
 
radiation have been published, and the reader is referred to these for a more
 
in-depth discussion (Hobbs and McClellan 1986; ICRP 1984; Mettler and Moseley
 
1985; Rubin and Casarett 1968).
 
B.4.1 Radiation Effects at the Cellular Level
 
According to Mettler and Moseley (1985), at acute doses up to 10 rad (100
 
mGy), single strand breaks in DNA may be produced. These single strand breaks
 
may be repaired rapidly. With doses in the range of 50 to 500 rad (0.5 to 5
 
Gy) , irreparable double-stranded DNA breaks are likely, resulting in cellular
 
reproductive death after one or more divisions of the irradiated parent cell.
 
At large doses of radiation, usually greater than 500 rad (5 Gy), direct cell
 
death before division (interphase death) may occur from the direct interaction
 
of free-radicals with essentially cellular macromolecules. Morphological
 
changes at the cellular level, the severity of which are dose-dependent, may
 
also be observed.
 
The sensitivity of various cell types varies. According to the Bergonig-

Tribondeau law, the sensitivity of cell lines is directly proportional to
 
their mitotic rate and inversely proportional to the degree of differentiation
 
(Mettler and Moseley 1985). Rubin and Casarett (1968) devised a
 
classification system that categorized cells according to type, function, and
 
mitotic activity. The categories range from the most sensitive type,
 
"vegetative intermitotic cells," found in the stem cells of the bone marrow
 
and the gastrointestinal tract, to the least sensitive cell type, "fixed
 
postmitotic cells," found in striated muscles or long-lived neural tissues.
 
Cellular changes may result in cell death, which if extensive, may
 
produce irreversible damage to an organ or tissue or may result in the death
 
of the individual. If the cell recovers, altered metabolism and function may
 
still occur, which may be repaired or may result in the manifestation of
 
clinical symptoms. These changes may also be expressed at a later time as
 
tumors or mutations.
 
B.4.2 Radiation Effects at the Organ Level
 
In most organs and tissues the injury and the underlying mechanism for
 
that injury are complex and may involve a combination of events. The extent
 
and severity of this tissue injury are dependent upon the radiosensitivity of
 
the various cell types in that organ system. Rubin and Casarett (1968)
 
describe and schematically display the events following radiation in several
 
organ system types. These include: a rapid renewal system, such as the
 
gastrointestinal mucosa; a slow renewal system, such as the pulmonary
 
epithelium; and a nonrenewal system, such as neural or muscle tissue. In the
 
rapid renewal system, organ injury results from the direct destruction of
 
highly radiosensitive cells, such as the stem cells in the bone marrow.
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Injury may also result from constriction of the microcirculation and from
 
edema and inflammation of the basement membrane (designated as the
 
histohematic barrier - HHB), which may progress to fibrosis. In slow renewal
 
and nonrenewal systems, the radiation may have little effect on the
 
parenchymal cells, but ultimate parenchymal atrophy and death over several
 
months result from HHB fibrosis and occlusion of the microcirculation.
 
B.4.3 Acute and Chronic Somatic Effects
 
B.4.3.1 Acute Effects. The result of acute exposure to radiation is
 
commonly referred to as acute radiation syndrome. This effect is seen only
 
after exposures to relatively high doses (>50 rad), which would only be
 
expected to occur in the event of a serious nuclear accident. The four stages
 
of acute radiation syndrome are prodrome, latent stage, manifest illness
 
stage, recovery or death. The initial phase is characterized by nausea,
 
vomiting, malaise and fatigue, increased temperature, and blood changes. The
 
latent stage is similar to an incubation period. Subjective symptoms may
 
subside, but changes may be taking place within the blood-forming organs and
 
elsewhere which will subsequently give rise to the next stage. The manifest
 
illness stage gives rise to symptoms specifically associated with the
 
radiation injury. Among these symptoms are hair loss, fever, infection,
 
hemorrhage, severe diarrhea, prostration, disorientation, and cardiovascular
 
collapse. The symptoms and their severity depend upon the radiation dose
 
received.
 
B.4.3.2 Delayed Effects. The level of exposure to radioactive
 
pollutants that may be encountered in the environment is expected to be too
 
low to result in the acute effects described above. When one is exposed to
 
radiation in the environment, the amount of radiation absorbed is more likely
 
to produce long-term effects, which manifest themselves years after the
 
original exposure, and may be due to a single large over-exposure or
 
continuing low-level exposure.
 
Sufficient evidence exists in both human populations and laboratory
 
animals to establish that radiation can cause cancer and that the incidence of
 
cancer increases with increasing radiation dose. Human data are extensive and
 
include epidemiological studies of atomic bomb survivors, many types of
 
radiation-treated patients, underground miners, and radium dial painters.
 
Reports on the survivors of the atomic bomb explosions at Hiroshima and
 
Nagasaki, Japan (with whole-body external radiation doses of 0 to more than
 
200 rad) indicate that cancer mortality has increased (Kato and Schull 1982).
 
Use of X-rays (at doses of approximately 100 rad) in medical treatment for
 
ankylosing spondylitis or other benign conditions or diagnostic purposes, such
 
as breast conditions, has resulted in excess cancers in irradiated organs
 
(BEIR 1980, 1990; UNSCEAR 1977, 1988). Cancers, such as leukemia, have been
 
observed in children exposed in utero to doses of 0.2 to 20 rad (BEIR, 1980,
 
1990; UNSCEAR 1977, 1988). Medical use of Thorotrast (colloidal thorium
 
dioxide) resulted in increases in the incidence of cancers of the liver, bone,
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and lung (ATSDR 1990a; BEIR 1980, 1990; UNSCEAR 1977, 1988). Occupational
 
exposure to radiation provides further evidence of the ability of radiation to
 
cause cancer. Numerous studies of underground miners exposed to radon and
 
radon daughters, which are alpha emitters, in uranium and other hard rock
 
mines have demonstrated increases in lung cancer in exposed workers (ATSDR
 
1990b). Workers who ingested radium-226 while painting watch dials had an
 
increased incidence of leukemia and bone cancer (ATSDR 199Oc). These studies
 
indicate that depending on radiation dose and the exposure schedule, ionizing
 
radiation can induce cancer in nearly any tissue or organ in the body.
 
Radiation-induced cancers in humans are found to occur in the hemopoietic
 
system, the lung, the thyroid, the liver, the bone, the skin, and other
 
tissues.
 
Laboratory animal data indicate that ionizing radiation is carcinogenic
 
and mutagenic at relatively high doses usually delivered at high dose rates.
 
However, due to the uncertainty regarding the shape of the dose-response
 
curve, especially at low doses, the commonly held conservative position is
 
that the cancer may occur at dose rates that extend down to doses that could
 
be received from environmental exposures. Estimates of cancer risk are based
 
on the absorbed dose of radiation in an organ or tissue. The cancer risk at a
 
particular dose is the same regardless of the source of the radiation. A
 
comprehensive discussion of radiation-induced cancer is found in BEIR IV
 
(1988), BEIR V (1990), and UNSCEAR (1982, 1988).
 
B.4.4 Genetic Effects
 
Radiation can induce genetic damage, such as gene mutations or
 
chromosomal aberrations, by causing changes in the structure, number, or
 
genetic content of chromosomes in the nucleus. The evidence for the
 
mutagenicity of radiation is derived from studies in laboratory animals,
 
mostly mice (BEIR 1980, 1988, 1990; UNSCEAR 1982, 1986, 1988). Evidence for
 
genetic effects in humans is derived from tissue cultures of human lymphocytes
 
from persons exposed to ingested or inhaled radionuclides (ATSDR 199Oc,
 
1990d). Evidence for mutagenesis in human germ cells (cells of the ovaries or
 
testis) is not conclusive (BEIR 1980, 1988, 1990; UNSCEAR 1977, 1986, 1988).
 
Chromosome aberrations following radiation exposure have been demonstrated in
 
man andn in experimental animals (BEIR 1980, 1988, 1990; UNSCEAR 1982, 1986,
 
1988).
 
B.4.5 Teratogenic Effects
 
There is evidence that radiation produces teratogenicity in animals. It
 
appears that the developing fetus is more sensitive to radiation than the
 
mother and is most sensitive to radiation-induced damage during the early
 
stages of organ development. The type of malformation depends on the stage of
 
development and the cells that are undergoing the most rapid differentiation
 
at the time. Studies of mental retardation in children exposed in utero to
 
radiation from the atomic bomb provide evidence that radiation may produce
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teratogenic effects in human fetuses (Otake and Schull 1984). The damage to
 
the child was found to be related to the dose that the fetus received.
 
B.5 UNITS IN RADIATION PROTECTION AND REGULATION
 
B.5.1 Dose Equivalent and Dose Equivalent Rate. Dose equivalent or rem
 
is a special radiation protection quantity that is used to express the
 
absorbed dose in a manner which considers the difference in biological
 
effectiveness of various kinds of ionizing radiation. The ICRU has defined
 
the dose equivalent, H, as the product of the absorbed dose, D, the quality
 
factor, Q, and all other modifying factors, N, at the point of interest in
 
biological tissue. This relationship is expressed as follows:
 
H = D x Q x N.
 
The quality factor is a dimensionless quantity that depends in part on the
 
stopping power for charged particles, and it accounts for the differences in
 
biological effectiveness found among the types of radiation. By definition it
 
is independent of tissue and biological end point and, therefore, of little
 
use in risk assessment now. Originally Relative Biolotical Effectiveness
 
(RBE) was used rather than Q to define the quantity, rem, which was of use in
 
risk assessment. The generally accepted values for quality factors for
 
various radiation types are provided in Table B-3. The dose equivalent rate
 
is the time rate of change of the dose equivalent to organs and tissues and is
 
expressed as rem/unit time or sievert/unit time.
 
B.5.2 Relative Biological Effectiveness. The term relative biologic
 
effectiveness (RBE) is used to denote the experimentally determined ratio of
 
the absorbed dose from one radiation type to the absorbed dose of a reference
 
radiation required to produce an identical biologic effect under the same
 
conditions. Gamma rays from cobalt-60 and 200 to 250 KeV X-rays have been
 
used as reference standards. The term RBE has been widely used in
 
experimental radiobiology, and the term quality factor used in calculations of
 
dose equivalents for radiation protection purposes (ICRP 1977; NCRP 1971;
 
UNSCEAR 1982). The generally accepted values for RBE are provided in Table
 
B-4.
 
B.5.3 Effective Dose Equivalent and Effective Dose Equivalent Rate. The
 
absorbed dose is usually defined as the mean absorbed dose within an organ or
 
tissue. This represents a simplification of the actual problem. Normally
 
when an individual ingests or inhales a radionuclide or is exposed to external
 
radiation that enters the body (gamma), the dose is not uniform throughout the
 
whole body. The simplifying assumption is that the detriment will be the same
 
whether the body is uniformly or nonuniformly irradiated. In an attempt to
 
compare detriment from absorbed dose of a limited portion of the body with the
 
detriment from total body dose, the ICRP (1977) has derived a concept of
 
effective dose equivalent.
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The effective dose equivalent, HE is
 
HE = (the sum of) Wt Ht 
where Ht is the dose equivalent in the tissue, Wt is the weighting factor,
 
which represents the estimated proportion of the stochastic risk resulting
 
from tissue, T, to the stochastic risk when the whole body is uniformly
 
irradiated for occupational exposures under certain conditions (ICRP 1977).
 
Weighting factors for selected tissues are listed in Table B-5.
 
The ICRU (1980), ICRP (1984), and NCRP (1985) now recommend that the rad,
 
roentgen, curie and rem be replaced by the SI units: gray (GY), Coulomb per
 
kilogram (C/kg), becquerel (Bq), and sievert (Sv), respectively. The
 
relationship between the customary units and the international system of units
 
(SI) for radiological quantities is shown in Table B-6.
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